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Combinatorial chemistry and high-throughput screening approaches utilized during drug
discovery have resulted in many potent pharmacologically active molecules with low aqueous
solubility and consequently poor bioavailability. Enabling technologies, such as amorphous solid
dispersions (ASD’s), can obviate these challenges and provide an efficient route to formulate the
drug as an oral solid dosage form. However, high-energy amorphous materials have an inherent
tendency to crystallize and in doing so can negate the apparent solubility advantage achieved by
using such formulations. Crystallization can occur during (1) cooling the drug molecule from the
melt state (such as during hot melt extrusion); (2) during storage of an amorphous formulation;
(3) during pharmaceutical processing unit operations such as compression, granulation etc.
Current knowledge with regards to the relationship between crystallization propensity of an
active pharmaceutical ingredient (API) from the amorphous state (supercooled liquid and glass)
and its thermodynamic, kinetic and molecular properties is limited. Furthermore, examining the
mechanistic steps involved in crystallization of organic molecules under conditions of
supercooling provides an opportunity to examine supramolecular aggregation events occurring
during early stages of crystallization. Studying crystallization mechanism from amorphous state
is important for pharmaceutical formulation development because a molecular-level
understanding of the crystallization process would provide clues regarding the intermolecular

xv
interactions at the early stages of nucleation and help in rational selection of polymeric
excipients to hinder such events.
The primary goal of this research is to develop an understanding of phase transition from
amorphous pharmaceuticals, specifically focusing on the role of thermodynamic, kinetic and
molecular properties of a series of structurally similar compounds. It is hypothesized that the
there exists a link between thermodynamics quantities, kinetic properties, molecular interactions
and glass forming ability. Furthermore, it is hypothesized that the molecular heterogeneity in
supercooled liquids and glassy state, manifested through intermolecular interactions and
conformational flexibility impacts the observed crystallization behavior.
Understanding the phase transition kinetics and mechanism of crystallization from amorphous
pharmaceuticals is critical for development of stable formulations for drug delivery. The specific
goals of this research include:
.

(1) Investigating the link between thermodynamic and kinetic factors affecting

the crystallization propensity of organic compounds from supercooled liquid state.
.

(2) Evaluating the role of intermolecular interactions and conformational

distribution on glass forming ability and stability.
.

(3) Examining the relationship between supramolecular aggregates present in

glassy state and polymorphic outcome.
It is believed that successful completion of this research will provide a fundamental
understanding of amorphous solid-state chemistry as well as provide useful tools for the
implementation of ASD’s as solid oral dosage forms.

1

CHAPTER 1.

1.1

INTRODUCTION

Pharmaceutical Materials Science and Solid-state Chemistry

Solid, liquid and gas are the three most commonly encountered states of matter. Each of these
states finds application in the pharmaceutical industry for delivery of drugs. Liquids are
encountered as oral (e.g. syrups and solutions) or parenteral (e.g. intravenous, subcutaneous or
intramuscular) formulations, while aerosolized drugs are often used for pulmonary delivery of
drugs. However, solid-state is the most preferred state of matter employed in formulation design
in the pharmaceutical industry in the form of tablets, powders and capsules. Solids offer greater
patience compliance, ease of manufacturing, and most importantly greater physical and chemical
stability.1
Materials science of active pharmaceutical ingredients (API’s) and excipients has become
increasingly important in the pharmaceutical industry. Solid-state chemistry of drugs retains its
importance throughout the drug development process.2 During early phase development, API
isolation after synthesis and solid-form screening are key steps prior to dosage form design and
manufacturing. Furthermore, solid-state technology of drugs plays an important role in
regulatory and post-marketing stages especially with regard to protection of intellectual property
and life cycle management.2-3
Material design in industries such as optoelectronics4 and metals/alloys5 differs significantly
from that in the pharmaceutical industry. In these industries, materials are engineered with
desirable properties already built into the system, for example, alloys with better corrosion
resistance; special glasses for use in optical fibers, and paints with greater weather resistance.
However, material (drug) design in pharmaceutical sector is largely driven by the
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pharmacological response so as to achieve desirable efficacy and safety profiles in vivo.6 With
advances in molecular biology and genetics, the targets for new compounds have become more
specific and complex, thereby resulting in large number of highly intricate molecules (high MW
and lipophilicity).2 While these highly potent compounds are designed for binding to their target,
their solid-state properties are not always conducive for oral drug delivery, especially due to their
poor aqueous solubility.6-7 While there seems to be a shift in the approach of the industry,
whereby ”drug-like” properties are built into molecule during lead optimization,2 in the
meantime nearly 90% of the drugs in drug pipelines suffer from solubility issues.3
Drug development scientists often approach the issues of poor solubility by invoking specific
formulation strategies. Several solid-state approaches have been devised to enhance the solubility
and consequently oral bioavailability of drugs. These include salts,8 co-crystal,9 and amorphous
solid dispersions10 (ASD’s) among others. Amongst these formulation options, ASD’s have
received considerable attention in the last two decades.11 While amorphous formulations lend
themselves to high apparent solubility and dissolution rates, they present several obstacles in
their implementation.
Firstly, it has been observed that not all compounds can be easily vitrified. While some
compounds are easily trapped in the amorphous state on cooling from the melt state (referred to
as good glass formers), others crystallize in the supercooled liquid regime (poor glass formers).12
Secondly, amorphous solids are unstable relative to their crystalline counterparts and have a
tendency to crystallize over time. This thermodynamically driven instability is the biggest
concern to physical stability of an amorphous formulation.13 Thirdly, the manufacturing
processes involved in drug product development may render an otherwise stable amorphous
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formulation susceptible to crystallization.14 Re-crystallization of an API in a dosage form can
significantly impact the drug product performance leading to sub-optimal therapeutic effects.
This work will focus on understanding the glass formation as well as crystallization from
amorphous state of organic drug molecules from a thermodynamic, kinetic and molecular
viewpoint. Furthermore, since organic molecular liquids provide a solvent free state of matter,
they provide an ideal system for studying the structure of the amorphous state as well as the role
of pre-nucleation events on crystallization kinetics and polymorph selection.

1.2

Crystalline and Non-crystalline solid state

Based on molecular ordering, solids can be classified into two main categories – crystalline
and non-crystalline. Since both these states are intricately linked and form the basis of this
research work, they will be discussed below in detail.
1.2.1 Crystalline solid state
Crystalline solid state is characterized by a three-dimensional lattice structure, where each
lattice point is occupied by a molecule (or atom). Molecular crystals display both short and longrange order. The smallest repeating unit, which can be used to build the entire lattice, is referred
to as the unit cell. The length of the unit cell vectors (a, b, c) and the angles () between
them are termed lattice parameters. The number of molecule in the unit cell is generally
represented by the symbol Z, while the symmetry independent molecules are represented by Z’.15
Crystalline solids almost always exist in more than one crystal structure. Such distinct solid
forms of the same molecular structure are referred to as polymorphs.16 Polymorphs, which differ
in the packing mode, are referred to as packing polymorphs while two crystal structures differing
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only in the molecular conformation are called conformational polymorphs.17 Often during the
crystallization process, solvents may be trapped in the crystal. Such solid modifications are
referred to as either solvates or hydrates.16
Polymorphs have different free energies and stabilities. Crystal structure with the least free
energy (at a given temperature/pressure) is called the stable polymorph and all other forms are
referred to as metastable forms.10 Based on their free energy-temperature diagrams polymorphs
can be divided into monotropic or enantiotropic systems.16 This classification is based on their
thermodynamic behavior especially with regards to the presence of transition temperature (Tr)
above or below the melting point of the two forms (Figure 1.1). The temperature at which two
crystal systems are equal in stability is called the transition temperature (Tr). For an enantiotropic
system, the transition temperature lies below the melting point of both the polymorphs.
Therefore, stability order of the polymorphs switches across Tr. A system is called monotropic if
Tr lies above the melting point of the two polymorphs and one solid form is stable under all
conditions.1c
The phenomenon of polymorphism is especially important in the pharmaceutical industry with
nearly 80% of the marketed drugs being polymorphic.18 As stated by McCrone, the discovery of
polymorphs is directly related to the time and effort spent on finding them.19 Different
polymorphs possess distinct physical and chemical properties. Solubility, dissolution rate and
subsequently bioavailability can be affected by an undetected polymorphic transformation.
Therefore, it is imperative that all possible polymorphic forms are detected as early in the drug
development process as possible and the most stable form (in most cases) is identified for
development.10
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1.2.1.1 Polymorph Crystallization
Solution crystallization was used during this research to obtain the polymorphic forms of
interest. This section describes solution crystallization for obtaining the desired polymorphic
form.
Solution crystallization is a unit operation of great significance to both organic and inorganic
chemical industries.20 Crystallization is used during several stages of pharmaceutical API
development. Polymorph screening in pharmaceutical industry involves using several solvents
with distinct properties to generate all possible crystal structures.21 Under the current paradigm,
many crystallization experiments are conducted on each new molecule to establish a
crystallization process. Furthermore, crystallization is a key unit operation for separation of
synthetic intermediates and obtaining the right polymorphic form of the API during process
scale-up.10 Crystallization controls the crystal structure, shape, size distribution and impacts
other downstream unit operations such as filtration and milling. Furthermore, in the
pharmaceutical industry, the property of the solid phase has an impact on the bio-performance
and shelf life of the drug product by impacting solubility/dissolution rate in bio-relevant media.20
Solution crystallization can be conducted by three different methods (1) Evaporative (2) Antisolvent (3) Cooling. Solvent evaporation provides a method for rapidly increasing
supersaturation levels and inducing crystallization. This method is often employed during
polymorph screening. Anti-solvent crystallization finds utility for crystallizing highly soluble
compounds. In this method, an anti-solvent is added to decrease the solubility of the desired
substance. Cooling crystallization is most commonly used in the pharmaceutical industry for
polymorph control and has been discussed below in detail.22
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Polymorphic outcome of a crystallization experiment depends on thermodynamic and kinetic
factors.20 Thermodynamic factors include solubility, temperature as well as interfacial tension
between solid-liquid phases and they impact the solubility vs. temperature phase diagram. Once
a metastable domain is encountered in a solubility vs. temperature diagram (Figure 1.2), the
crystallization outcome depends on the kinetic factors, which includes factors such as
supersaturation, nucleation rate and molecular mobility, and specific solute-solvent
interactions.23
Solvents may or may not influence polymorphic outcome. One needs to understand the role of
thermodynamics on crystallization before understanding the regions of the phase diagram where
solvents can affect the crystallization outcome. This complex relationship between
thermodynamics and kinetics is well explained by Threlfall in his elegant use of the phase
diagram shown in Figure 1.2.24 Solubility curves, along with metastable zone width, are shown
for a dimorphic system. At A1 and G1, polymorph I and polymorph II crystallize exclusively.
The solvent does not affect the outcome. However, at point C1, the solution is metastable with
respect to both polymorphs. The form that crystallizes is dependent on kinetic factors, which are
effected by the solvent. Specific solute-solvent interactions can stabilize a metastable polymorph
by slowing the transformation kinetics to the stable form.21
After analyzing the phase diagram for a polymorphic drug, establishing a crystallization
procedure that consistently yields the correct solid form is not straightforward. This is evidenced
by the occurrence of phenomena such as concomitant polymorphism25 and disappearing
polymorphs26, which forces a crystallization scientist to be mindful of the fact that complex
interplay between thermodynamic and kinetic parameters can lead to difficulty in establishing a
crystallization procedure.25-26 Therefore, understanding the interplay of thermodynamics, kinetics
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and molecular recognition specifically the role of solvent - once the phase diagram has been
established - on nucleation and crystallization is critical for selective crystallization of the
desired polymorph.
The role of solvent in polymorphism has been examined for several molecules.21, 23, 27 In a
study conducted by Khoskhoo et al., the authors attempted to crystallize sulfathiazole
polymorphs by systematically varying the supersaturation in a set of four different
solvents/solvent mixtures. Rather than following the anticipated Ostwald rule of stages,
according to which the metastable form should crystallize first followed by the more stable forms,
only a particular polymorph could be obtained from a specific solvent system. The adsorption of
solvents to particular face of the growing crystal was deemed as the reason for selective
crystallization of polymorphs.21 Effect of solvent on polymorphic phase transformation of
sulfamerazine was studied by Gu et al. The authors concluded that the nucleation rate in different
solvents is dependent not only on the solubility but also on the strength of solute-solvent
interactions.28 In contrast to these results, Kelly et al. concluded that the hydrogen bond
donating/accepting ability of a solvent correlated with nucleation of carbamazepine polymorphs
rather than the strength of solute-solvent interactions.23 In a recent publication, a study was
conducted by Khamar et al., and the role of solvent on nucleation kinetics of salicylic acid was
examined. It was observed that the nucleation becomes increasing difficulty in the order:
chloroform, ethyl acetate, acetonitrile, acetone, methanol, and acetic acid. Using spectroscopic
and computational methods, it was shown that the nucleation order was related to the strength of
solute-solvent interactions. The solvent with greater strength of interactions leads to slower
nucleation as desolvation becomes more difficult.29 Thus, these reports provided contrasting
conclusions on the role of solvents on nucleation kinetics with some implicating the strength of
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solute-solvent interactions and others the hydrogen bonding donor/acceptor capabilities of the
solvent.
The role of solvent on nucleation has also been studied from the perspective of hydrogenbonded aggregates present in solution. Several reports have been published in the last two
decades examining clustering of solutes in a variety of solvents.30 One of the earliest reports of
the presence of pre-nucleation aggregates in supersaturated solutions was given by Mullin et al.
in 1965.30a They based their conclusion on the presecne of a concentration gradient in aqueous
citric acid solutions.30a Moreover, the role of solvents in promoting formation of pre-nucleation
aggregates that then crystallize with the same motif - link hypothesis - has gained momentum in
the last 15 years.31 One of the earliest reports in this area was from Roger Davey’s group. Davey
et al. observed that 2,6-dihydroxybenzoic acid (DHB), crystallizes as Form 1 polymorph (dimer)
from toluene and Form 2 from chloroform (chains) solutions. They demonstrated the presence of
dimers and chains of DHB in toluene and chloroform respectively, and concluded that specific
interaction of chloroform with carbonyl and hydroxyl groups seen on the (301) phase of the
crystal promotes formation of the chain motif in solution, leading to crystallization of Form 2.
Also, the formation of dimers in toluene is considered to maximize the solute-solute interactions
while minimizing the unfavorable polar-nonpolar interactions between the solute and solvent.32
The link between solution speciation and crystallization has also been explored for small
carboxylic acid molecules. It was observed that for benzoic acid and tetrolic acid, the solvent
directed the formation of pre-nucleation aggregates with specific motif and the solid crystallized
from such solvents reflected the same synthon in the crystal structure.33 Reports of such a link
have also been described for Acridine,31 Tolfenamic acid,34 carbamazepine,35 isonicotinamide,36
and some other molecules. On the other hand, for mandelic acid, such a direct link between
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solution species and crystal synthon was not observed and it was concluded that significant
rearrangement must occur within the developing nucleus before crystallization.33b
Designing a crystallization process is a challenging endeavor. Polymorphism is influenced by
thermodynamic and kinetic factors. Besides understanding the thermodynamic relationship of
polymorphs, choosing the right solvent and adopting the correct crystallization methodology
(cooling, anti-solvent, evaporative or melt) is critical. Due to the intricate relationship between
the above-mentioned factors, developing a crystallization scheme that reproducibly generates the
desired polymorph with adequate purity remains challenging.
1.2.2 Non-Crystalline state (Amorphous state)
The conspicuous difference between crystalline solids, discussed in the previous section, and
non-crystalline state (amorphous state) is the lack of long-range three-dimensional translational
symmetry of the building blocks (atoms, molecules or ions).37 Furthermore, the amorphous state
is divided into two distinct phases – supercooled liquid and glassy solid - with distinctive yet
complementary thermodynamic and kinetic properties. Supercooled liquid refers to a state which
has been cooled below its melting point, while glassy solids are the consequence of cooling the
supercooled liquid below a temperature, referred to as the glass transition temperature (Tg).38 The
relationship between these different phases is best illustrated with a phase diagram as shown in
Figure 1.3, which shows the plot of specific volume (a similar plot is obtained on graphing other
thermodynamic quantities such as enthalpy or entropy) versus temperature.39
As the temperature of an one-component liquid is lowered towards its melting point (Tm), it
may undergo one of the two possibilities; a first order phase transition leading to crystallization
(characterized by a sharp decrease in specific volume) or it could enter the supercooled liquid
domain (the specific volume values here reflect the low temperatures extrapolated values for the
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liquid above Tm). As the temperature is reduced further, an increase in viscosity leads to a
decrease in molecular motion, and at a certain temperature, the value of specific volume cannot
attain equilibrium for that temperature, and the slope of the line representing the supercooled
melt changes. The temperature range at which this happens is called the glass transition
temperature (Tg) and the system enters the thermodynamically unstable glassy state. While the
specific volume of glass continues to decrease its thermal expansion coefficient (derivative of
specific volume with temperature) is much closer to the crystalline state than the liquid state.40
For this report, amorphous state has been divided into three domains – (1) Supercooled liquids,
(2) The transformation range or Tg and (3) Glassy solids, and each of these domains have been
discussed below.
1.2.2.1 Supercooled Liquids
1.2.2.1.1 Observables: Thermodynamic and Dynamic Properties
Crystalline solid is thermodynamically most stable state below the melting point. However,
since certain compounds can remain stable for long periods (e.g. o-terphenyl) below their
melting temperature, supercooled liquids are regarded as an “equilibrium state” if no crystal
nuclei are present during the timescale of observation.40 Furthermore, this assumption forms the
basis of much of the mathematical theory developed to explain the physics of supercooled
liquids.40-41
Thermodynamic parameters such as specific volume, heat capacity, entropy and enthalpy
display interesting behaviors on supercooling. Specific volume and enthalpy versus temperature
have been discussed in the previous section. Interesting behavior is observed for heat capacity
with supercooling (Figure 1.4). Cp increases continuously between Tm and Tg, and then suddenly
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drops to values resembling that of crystals near Tg.39 Experimentally determined heat capacity
values can be used to calculate the specific entropy, s, of the supercooled liquid (“equilibrium
state” assumption) using the following expression
𝑇 𝐶𝑝 (𝑇)

s(𝑇2 ) – s(𝑇1 ) = ∫𝑇 2
1

𝑇

dT

Equation 1.1

where, 𝑇2 = Tm and 𝑇1 = temperature of the supercooled liquid.39 Entropy at Tm is calculated by
adding the entropy of fusion to the crystal entropy. And the crystal entropy can be obtained by
measuring the heat capacity from T = 0 to Tm. As can be inferred from equation 1.1, as heat
capacity increases with supercooling, entropy decreases.41-42
Dynamics of supercooled liquids is probed primarily by two techniques: viscosity
measurements or relaxation time measurements. Supercooling leads to rapidly rising viscosity
with values of 1013 Pa.s. near Tg. Vogel-Tammann-Fulcher or VTF equation is used to model the
temperature dependence of viscosity, 𝜂, (or relaxation time) and is given as
𝐵

𝜂 = 𝜂0 𝑒𝑥𝑝(𝑇−𝑇 )
0

Equation 1.2

𝐸

where, B = 𝑘 , and E = activation energy barrier and k is the Boltzmann constant.41 When 𝑇0 = 0,
the relaxation time shows an Arrhenius temperature dependence, while if 𝑇0 > 0, non-Arrhenius
temperature dependence is expected. At T = 𝑇0 , this equation predicts that the relaxation time or
viscosity will acquire an infinite value.43
Depending on the nature of viscous slowdown of liquids on decreasing temperature,
supercooled liquids are described as either strong or fragile.44 Strong liquids show Arrhenius
temperature dependence of viscosity and resist structural change with decreasing temperature.
On the other hand, fragile liquids demonstrate non-Arrhenius temperature dependence of
viscosity between Tm and Tg and decreasing temperature is accompanied by significant structural
change.42 Open network-forming liquids which interact by covalent bonding (such as SiO2)
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generally act as strong liquids while molecules that interact through Coulombic/Van der Waal
interactions (o-terphenyl) behave as fragile liquids.40
Like viscosity, the relaxation time rises rapidly with increasing supercooling. Furthermore,
relaxation processes near Tg can be divided into two categories: primary and secondary.45 The
process with the longest relaxation time is referred to as the process and corresponds to
molecular rotation. The faster processes are referred to as secondary and constitute the fast and
slow (Johari-Goldstein) processes, which correspond to reorientation and cage rattling processes
respectively.46
Temporal behavior of a response function, F(t), – such as polarization on applying an electric
field or strain from stress- near Tg has been observed to show a non-exponential relaxation
behavior.47 This contrasts with the exponential behavior of liquids above Tm. This time
dependent response on perturbation has been described by the Kohlraush-Williams-Watts
(KWW) equation or the stretched exponential
𝑡

∅(t) = exp (- (𝜏)𝛽 )

Equation 1.3

where, 𝜏 = relaxation time and 𝛽 = exponent which is between 0 and 1.40-41 Such behavior can be
attributed to either the presence of heterogeneity in the supercooled liquid with each domain
relaxing in a homogeneous manner or the presence of a homogeneous environment where each
domain relaxes non-exponentially.45
1.2.2.1.2 Theories describing Supercooled liquids
Several theories have been proposed to explain the dynamics of supercooled liquids. One
common feature of these theories is to try to explain the increase in the relaxation time or
viscosity with lowering temperature.41 Generally, in physics, a divergent relaxation time for an N
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body system is associated with an increase in the size of the number of bodies being
rearranged.47

Thus, under these theories, increase in the relaxation time/viscosity is often

positively correlated with correlation length. Correlation length refers to the change in the size of
the correlated regions on supercooling (generally, correlation length for a system is determined
from the correlation function of the order parameter).
Connection between thermodynamics and dynamics is provided by the Adam-Gibbs theory.41
Adam-Gibbs theory explains relaxation behavior as a function of the temperature variation of the
size of “cooperatively rearranging regions (CRR’s)”.39 Under theories such as the Adam-Gibbs
theory, increase in relaxation time is often correlated with a need to rearrange a larger region
(CRR’s) at low temperatures. From Equation 1.4, the viscous slowdown is explained because of
the decrease in the number of configurations that the system can sample near Tg.
𝐶

𝜏 = 𝜏0 𝑒𝑥𝑝(𝑇𝑆 )
𝑐

Equation 1.4

where, 𝑆𝑐 = configurational entropy; C and 𝜏0 are constants. However, this theory does not
provide insight into the size of the CRR’s and discounts the spatial heterogeneity associated with
supercooled liquids.40-41
The energy landscape model (by Goldstein) of supercooled liquids attempts to relate the
thermodynamics with dynamics.39 An energy landscape is the potential energy function of an Nbody system, 𝜓 (𝑟1 … 𝑟𝑁 ), where the vectors 𝑟𝑖 comprise the position, orientation and vibration
coordinates.39 This view of the supercooled liquid provides a connection between the dynamics
and the temperature dependence of sampling of the thermodynamic energy landscape. The
molecular dynamics simulation results of energy versus temperature for a binary mixture of
unequally sized Leonard-Jones particles shows that at high temperatures, the system samples
shallow minima as it can overcome high-energy barriers because of the high kinetic energy
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available, but at low temperatures, the system is unable to overcome high-energy barriers and is
forced to sample deeper minima.40 This is when the relaxation behavior changes from
exponential to stretched exponential (with respect to time) and becomes non-Arrhenius (with
respect to temperature).40
The strong and fragile classification discussed above can also be understood in terms of the
energy landscape model. While strong liquids are thought to have a single mega basin, fragile
liquids potentially have multiple well-separated mega basins.45 Unlike strong liquids, the
activation energy for fragile glass formers increases with supercooling. This can be explained as
follows. At high temperatures, energy barriers can be overcome easily as only a small number of
molecules need to be rearranged cooperatively (and this allows for short relaxation times).
However, at T = Tg, the large activation energy and relaxation times are due to the need to
cooperatively rearrange many coupled molecules.40 Finally, the energy landscape model can also
be used to explain decoupling of  and  relaxations. According to this theory, while 
relaxations correspond to configurational sampling of neighboring mega basins, -processes
correspond to elementary relaxations between adjacent basins.41, 47
1.2.2.2 Glass Transition Temperature
Tg is defined as the temperature range occurring at the intersection of the supercooled liquid
and glassy curves in a specific volume versus temperature plot (Figure 1.3). Glass transition is a
kinetic phenomenon and depends on the cooling rate employed and thermal history of the sample.
It is often observed at the temperature at which the relaxation time is of the order of 100 seconds
and the viscosity reaches a value of 1013 poise.38
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As mentioned earlier, the heat capacity (Cp) decreases sharply at Tg. If however, the Cp, does
not drop at Tg, the entropy of liquid will continue to decrease (Equation 1.1) and would
eventually have the same value as that of a crystal. The temperature at which this would happen
is called the Kauzmann temperature, Tk. As the liquid is further cooled, liquid would have a
lower entropy than crystal and eventually, if Tg event does not occur, it would be negative at a
temperature above T = 0. The latter is a violation of the Third Law of Thermodynamics. Thus,
according to Kauzmann, Tg, must occur at a temperature above Tk.48 The imminent
thermodynamic entropy crisis on supercooling, often referred to as the Kauzmann paradox, is
averted by Tg. Therefore, Tg is often described as the kinetic manifestation of an underlying
thermodynamic phase transition to an ideal glass.40
Ehrenfest described phase transitions to be either first order or second order.49 A first order
phase transition is characterized by a sharp change in the volume, enthalpy, and entropy at the
transition temperature. Since this discontinuity is not seen at Tg, instead a gradual change occurs;
it may be referred to as a second order phase transition. However, thermodynamic variables such
as heat capacity, isothermal compressibility and thermal expansion do show such discontinuity.
Furthermore, to be classified as a true second order phase transition, the configurational entropy
of the glass and melt state are expected to be equal at Tg. However, as the system is cooled the
configurational entropy of the system decreases due to an increase in viscosity leading to nonoccurrence of a true phase transition and a glass transition is instead observed. Therefore, Tg is
often referred to as a pseudo-second order phase transition.49
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1.2.2.3 Glassy State
1.2.2.3.1 Structure
As the name suggests, amorphous solid state is characterized by a lack of molecular order, and
this state of matter lies between solids and liquids in terms of molecular ordering.37 As expected
it is an extension of the supercooled liquid state. Although, this nebulous phase is often
considered to be structurally undefined, it often possesses short-range order in the form of
hydrogen-bonded aggregates.50 Moreover, for a conformationally flexible molecule, this would
mean that unlike in a crystalline lattice, the molecular conformation can vary considerably.
1.2.2.3.2 Methods of Preparation
Amorphous solids may be produced intentionally or unintentionally. Most commonly
employed industrial processes for amorphization are spray drying, hot melt extrusion and freezedrying.51 In the laboratory setting, melt quenching, cryogrinding, and solvent evaporation and
condensation from the vapor state are often employed. Unintentional amorphous form generation
can happen during pharmaceutical unit operations such as grinding, milling and wet granulation.
Furthermore, drying of hydrates has also been shown to lead to amorphous formation.51
1.2.2.3.3 Thermodynamics of Glassy state
Thermodynamics of amorphous solids is characterized by greater Gibbs free energy compared
to the crystallize state. This free energy difference, Δ𝐺 𝑎,𝑐 (T), can be estimated using the
Hoffman equation,13
Δ𝐺 𝑎,𝑐 (T) = [

Δ𝐻𝑓 ∗ ∆𝑇
𝑇𝑚

𝑇

] (𝑇 )
𝑚

Equation 1.5
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where, Δ𝐻𝑓 = enthalpy of fusion, ∆𝑇 = supercooling and 𝑇𝑚 = melting temperature.
The derivation of Hoffman equation is based in the assumption that the temperature range for
the system under consideration lies between the melting point and the glass transition
temperature. Furthermore, a linear relationship between heat capacity and temperature, as well as
a constant difference between the heat capacity of solid and liquid is assumed.52
This high-energy state possesses excess thermodynamic properties, gradually drifting towards
equilibrium leading to either nucleation and subsequent crystallization or structural relaxation
(annealing) to a lower energy glassy state.37

1.3

Crystallization Theory

Since this research deals with the physical stability associated with amorphous
pharmaceuticals, it is essential to discuss the theory and mechanisms associated with
crystallization. Crystallization involves two steps – nucleation and growth. Nucleation can be
either primary or secondary. Primary nucleation is further subdivided into homogeneous or
heterogeneous. Each of these sub-topics has been discussed below.
1.3.1 Nucleation
Nucleation is the initiation of phase transition and involves interaction and assembly of solute
molecules in the early stages of liquid-to-solid transition. Nucleation controls the crystalline
outcome, morphology and crystal size distribution. However, the early events involved in
formation of a new crystalline phase are not well understood at the moment.20 Deciphering the
nucleation mechanism has proven to be a challenge for crystallization scientists.
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Nucleation is challenging to study experimentally and computationally. Nuclei of molecular
crystals are composed of a few hundred molecules and are in the nanometer size range, thus,
preventing direct observation with current analytical techniques.20 Furthermore, computational
techniques are limited by the time scale of nucleation and complexity rendered by factors such as
solvent and molecular conformation influencing this stochastic event.20 The classical mechanism
for nucleation is called the Classical Nucleation Theory (CNT), while the more recent, nonclassical mechanism, is called the two-step nucleation theory. Both these theories of nucleation
are discussed below.
1.3.1.1 Classical Nucleation Theory (CNT)
The classical theory, developed initially to describe condensation of vapor, has traditionally
been used to describe the kinetics of nucleation from solutions and melts.20 According to this
theory, when a system encounters a metastable domain – supersaturated solution or supercooled
melt - the free energy change needed to form a new phase ∆𝐺 is a sum of surface free energy
change, ∆𝐺𝑠 , i.e. free energy difference between the surface of the particle and bulk of the
particle, and the volume free energy change, ∆𝐺𝑉 , i.e. free energy difference between a very
large particle and the solute in liquid state (Figure 1.5).
∆𝐺 = ∆𝐺𝑠 + ∆𝐺𝑉

Equation 1.6

For a spherical solid particle of radius r,
∆𝐺 = 4𝜋 𝑟 2 𝛾 +

4
3

𝜋 𝑟 3 ∆𝐺𝑣

Equation 1.7

where, ∆𝐺𝑣 = free energy change of transformation/volume and 𝛾 = interfacial tension between
crystalline surface and supersaturated solution.20
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The surface free energy change is proportional to the interfacial tension between the liquid and
the nucleus surface as well as the size of the surface. This leads to an increase in net free energy
of the system on nucleation. On the other hand, the free energy change of transformation (a
negative quantity) is proportional to the volume of the nucleus and decreases with the growth of
the cluster. Therefore, the net free energy change associated with nucleation is a balance between
increase in ∆𝐺𝑠 - which favors dissolution of the nucleus - and decrease in ∆𝐺𝑉 - which promotes
growth – and therefore passes through a maximum.53
This maximum value associated with the free energy is called the activation barrier for
nucleation, ∆𝐺𝑐𝑟𝑖𝑡 , and the corresponding radius of the spherical cluster is referred to as the
critical nucleus size, 𝑟𝑐𝑟𝑖𝑡 .54
2𝛾

𝑟𝑐𝑟𝑖𝑡 = − ∆𝐺

Equation 1.8

𝑣

16 𝜋 𝛾3

∆𝐺𝑐𝑟𝑖𝑡 = 3 (∆𝐺

𝑣

=
)2

4 𝜋 𝛾 𝑟𝑐𝑟𝑖𝑡 2

Equation 1.9

3

The rate of nucleation is described by an Arrhenius-type rate equation
J = A exp (-

∆𝐺𝑐𝑟𝑖𝑡
𝑘𝑇

)

Equation 1.10

where, k = Boltzmann constant; T = Temperature in kelvin.53
∆𝐺𝑐𝑟𝑖𝑡 can be re-written by combining the Gibbs-Thomson equation (ln S =
2𝛾
𝑟

=

𝑘 𝑇 ln 𝑆
𝑣

, as
16 𝜋 𝛾3 𝑣 2

∆𝐺𝑐𝑟𝑖𝑡 = 3 (𝑘𝑇 ln 𝑆)2
𝑐

Equation 1.11

where, S = super saturation ratio (𝑐 ∗) and v = molecular volume.22
Finally using equation 1.10,

2𝛾𝑣
𝑘𝑇𝑟

) and −∆𝐺𝑣 =
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16 𝜋 𝛾3 𝑣2

J = A exp (- 3 𝑘 3 𝑇3 (ln 𝑆)2 )

Equation 1.12

Several observations make the classical theory inaccurate and are summarized below – (1)
According to CNT, embryo building units, considered as monomers in the original CNT
description, come together in a sequential manner to form the cluster. Only the size of the
aggregates is used to describe an aggregate as critical with the structure of the embryo
considered same as that of the final crystal structure. This is insufficient to describe
crystallization from solution, as both order parameter and density are needed to fully distinguish
between new and old phase and the structure of the aggregates may be different from that of the
final crystal structure (2) Furthermore, under CNT the fluctuations in density and order are
thought to happen simultaneously. Several molecules show transient disordered phases (3) The
nucleus-liquid interface is modeled as an infinite plane thereby neglecting the influence of
curvature on interfacial tension which is not valid for nuclei of size of nanometer (4) Although
the theory is widely used to treat kinetic data, it fails to predict correct results for simple onephase system such as condensation of water (5) No molecular level information is provided by
CNT.20, 55
1.3.1.2 Two-step Nucleation Theory
The non-classical theory of nucleation is called Two-step nucleation theory.56 As the name
suggests, it involves two stages during which nuclei are formed – (1) Formation of a disordered
ensemble from the solute molecules (2) Reorganization within the cluster leading to formation of
crystalline nuclei. Unlike CNT, this theory decouples density fluctuation from re-ordering
processes.53 The two-step theory has been gaining traction because forming an amorphous
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cluster and subsequent crystallization may provide a free energy advantage over the classical
route where individual molecules aggregate to form the crystal structure.56
1.3.1.3 Heterogeneous Nucleation
Heterogeneous nucleation refers to induction of phase transition non-spontaneously due to the
presence of foreign bodies such as dust/scratched surfaces (unintentional) or polymer
surfaces/seeding (intentionally). In fact, all nucleation events are thought to be initiated in a
heterogeneous fashion since it is extremely difficult to eliminate the presence of heterosurfaces.57
A hetero-surface can potentially induce nucleation at a degree of supercooling or
supersaturation higher than that needed for homogeneous nucleation. The presence of such a
surface impacts nucleation kinetics by lowering the overall free energy change (the critical
nuclear size does not change) and can be represented mathematically as
∆𝐺′𝑐𝑟𝑖𝑡 = ∅ ∆𝐺𝑐𝑟𝑖𝑡

Equation 1.13

where, ∅ is less than 1 and greater than 0.22
The interfacial tension relationship between the hetero-surface, crystalline deposit and the
supersaturated solution can be represented as
𝛾𝑠𝑙 = 𝛾𝑐𝑠 + 𝛾𝑐𝑙 cos 𝜃
cos 𝜃 =

𝛾𝑠𝑙 −𝛾𝑐𝑠
𝛾𝑐𝑙

Equation 1.14
Equation 1.15

where, 𝛾𝑐𝑠 = interfacial tension between crystalline deposit and hetero-surface; 𝛾𝑠𝑙 = interfacial
tension between hetero-surface and liquid; 𝛾𝑐𝑙 = interfacial tension between crystalline deposit
and liquid. The angle 𝜃 corresponds to the angle of contact between the crystalline deposit and
the hetero-surface.27b

22
The factor ∅ is expressed as
∅=

(2+ cos 𝜃) (1− cos 𝜃)2
4

Equation 1.16

For no affinity between the crystalline deposit and hetero-nuclei, 𝜃=180°, the critical free
energy nucleation barrier is the same as that for homogeneous nucleation. If 0° < 𝜃 < 180°, then
nucleation is easier than spontaneous nucleation. Finally, for 𝜃= 0°, there is need for nucleation
in the solution i.e. seeding of the solution with crystals (secondary nucleation).22, 27b
1.3.1.4 Link Hypothesis
Over the last decade there have been several reports of observation of pre-nucleation
aggregates of organic solute molecules in solution.27a,
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A pre-nucleation aggregate may be

defined as a self-association of solute molecules by intermolecular interactions usually hydrogen
bonds. These aggregates may be carboxylic acid dimers or chains, acid–amine catemers or even
higher order aggregates formed by Van der Waals interactions. Attempts have been made to link
these solution species to the synthon in the final crystal structure thereby leading to the
emergence of what is referred to as the Link Hypothesis.54 One must be careful, with respect to
the nucleation mechanism as nucleation may occur by sequential addition of these pre-nucleation
aggregates or from re-ordering within a transient cluster. Thus, link hypothesis is amenable to
both nucleation mechanisms specified above.
1.3.2 Crystal Growth Theories
A crystal nucleus, formed by overcoming the nucleation barrier, grows into an observable
crystal by attachment of solute molecules (or growth units). This crystal growth phenomenon has
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been studied for over 50 years and has led to several theories. Theories relevant to this work are
discussed below.
1.3.2.1 Surface Energy Theories
According to this theory, formalized by Gibbs, a crystal in equilibrium with its surroundings
tries to attain a minimum value for its total free energy (surface and volume) per unit volume (at
a fixed temperature and pressure) during growth.58 If the volume free energy per unit volume is
assumed to be constant, then, mathematically
∑𝑛1 𝑎𝑖 𝑔𝑖 = 𝑚𝑖𝑛𝑖𝑚𝑢𝑚

Equation 1.17

where, n = number of faces of the crystal, 𝑎𝑖 = area of the i th face, and 𝑔𝑖 = surface free
energy/area of the i th face. This implies that crystal growth leads to morphology with a
minimum total surface free energy per unit volume.
Furthermore, this theory puts forward a relationship between the surface free energy, rate of
growth and lattice density of the growth plane. According to Wulff, the rate of growth of a face
is directly proportional to the surface free energy. Moreover, it is postulated that the rate of
growth and surface energy should be inversely proportional to the lattice density of the growth
plane under discussion, suggesting rapid growth of faces with low lattice density.59 Surface
energy theories are largely historical, with minimal quantitative evidence and inability to explain
the role of supersaturation on crystal growth rate.22
1.3.2.2 Layer Growth Theories
The underlying postulate of layer growth theories is the presence of an adsorbed layer of
growth units (atoms, molecules) on the crystal face. According to the Gibbs-Volmer theory, the
initiation of growth on the face of a crystal involves two-dimensional nucleation, which leads to
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formation of a “center of crystallization”. The growth units are then adsorbed on the surface of
the plane at positions where the attractive force is greatest. The adsorbed layer can migrate over
the surface of the face until they reach the desired location. This build-up continues stepwise
until the entire face of the crystal is complete.60
The 2-D nucleation can be described by the Classical nucleation theory.22 For a circular disc
(cylindrical) nucleus of radius r and height h, the total free energy is given as
∆𝐺 = 2𝜋rh 𝛾 + 𝜋𝑟 2 h ∆𝐺𝑣

Equation 1.18

Upon maximization, the critical size,𝑟𝑐 , is determined as
𝛾

𝑟𝑐 = ∆𝐺

Equation 1.19

𝑣

which is half the radius for a 3-D nucleus. And the critical free energy barrier, ∆𝐺𝑐𝑟𝑖𝑡 , is
expressed as
𝜋ℎ𝛾2

∆𝐺𝑐𝑟𝑖𝑡 = − 𝑘 𝑇 ln 𝑆

Equation 1.20

Comparing ∆𝐺𝑐𝑟𝑖𝑡 for 3-D and 2-D nucleation shows that the ratio of energy requirements of a
16𝛾𝑣

sphere: disc is 3ℎ 𝑘 𝑇 ln 𝑆. Using some standard values, it can be shown that for S = 1.1, the ratio of
energy requirements is 50: 1. Thus, 2-D nucleation requires high levels of local super saturation
but it is lower than that required for 3-D nucleation.22
According to the Kossel-Stranski model of crystal growth, a crystal face can be envisioned as
composed of flat surfaces or terraces, and raised layers or steps. Two sites for attachment of
growth units are possible – a ledge site (two surfaces interact) or a kink site (6 surfaces interact).
Since the kink site provides the greatest contact and stability it is the favored site.61
The pre-requisite for growth by this model is the presence of steps (and kinks). Steps can be
created either by 2-D nucleation or by dislocations. Since reasonable high super saturation is
needed for 2-D nucleation, this theory fails to explain the behavior at moderate or low super
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saturation values. However, most crystal surfaces have imperfections. The most common of
these surface defects are the screw dislocations. These dislocations provide a starting point for
crystal face to grow “up a spiral staircase” without the need for 2-D nucleation.22
1.3.2.3 Crystallization from Melts
Crystallization from supercooled melts also involves nucleation and crystal growth. The
Classical nucleation mechanism, as applicable to solutions has been described above. The rate
expression for homogeneous nucleation from melts can be derived using similar fundamental
reasoning. One obvious difference is that the term for super saturation, S, needs to be replaced
with the term for degree of supercooling. To do so, ∆𝐺𝑣 is re-written as
∆𝐺𝑣 =

∆𝐻𝑓 ∆𝑇

Equation 1.21

𝑇∗

where, ∆𝐻𝑓 = heat of fusion; ∆𝑇 = degree of supercooling = (𝑇 ∗ - T); 𝑇 ∗ = solid-liquid melting
temperature in kelvin.13, 22
From equation 1.8 and 1.28, the 𝑟𝑐𝑟𝑖𝑡 for a supercooled melt is given as
2 𝛾 𝑇∗

𝑟𝑐𝑟𝑖𝑡 = − ∆𝐻

𝑓

Equation 1.22

∆𝑇

This relationship highlights that the size of the critical nucleus decreases with increasing level
of supercooling. Using the above relationship, an expression for ∆𝐺𝑐𝑟𝑖𝑡 can be formulated and
used to obtain the rate of nucleation equation
16 𝜋 𝛾3

J = A exp (- 3𝑘𝑇 ∗ ∆𝐻

𝑓

2

𝑇𝑟 (∆𝑇𝑟 )2

) Equation 1.23

where, 𝑇𝑟 = T/𝑇 ∗ , is the reduced temperature and ∆𝑇𝑟 = ∆𝑇 /𝑇 ∗ .
This analysis highlights that 𝑟𝑐𝑟𝑖𝑡 ~ 1/ ∆𝑇 and ∆𝐺𝑐𝑟𝑖𝑡 ~ 1/ (∆𝑇 )2 , i.e. with increasing
supercooling the nucleation barrier decreases more rapidly than the size of the critical nucleus.

26
These results imply that with decreasing temperature the rate of nucleation would keep on
increasing indefinitely, however, this is not what is seen experimentally.22
From the work of Tamman62 it has been noted that rate of nucleation in melts increases with
supercooling, reaches a maximum and then decreases. This behavior has been attributed to the
increase in viscosity with decreasing temperature, which restricts molecular movement and
decreases J. The term for viscosity (or kinetic barrier to nucleation) under the umbrella of CNT is
generally represented in two ways – either as a part of the pre-exponential term or as the part of
the exponential term. The pre-exponential term, A, in equation 30, is interpreted as the
“attachment frequency” of the growth unit to the nucleus from the supercooled liquid.57 As the
temperature decreases, pre-exponential factor A scales down as an inverse function of the
viscosity. As a part of the exponential term, viscosity can be represented as the kinetic barrier to
nucleation, ∆𝐺𝑛
J = A exp (-

∆𝐺𝑐𝑟𝑖𝑡 +∆𝐺𝑛
𝑘𝑇

)

Equation 1.24

Similarly, the crystal growth process described for solutions are applicable to melts. However,
some differences need to be highlighted. Firstly, while diffusion of the growth unit from the bulk
to the surface and surface integration are common to both, since there is presence of no solvent,
desolvation does not contribute to the kinetics of the process. Often the rate-limiting step of melt
crystallization is the rate of heat transfer from the crystal to the bulk liquid. Since on deposition
of solid mass there is liberation of heat of crystallization, the crystal surface temperature (𝑇 ∗ ) is
slightly higher than the temperature of the supercooled melt (T). Considering a stagnant layer at
the interface of crystal-liquid with a temperature, 𝑇𝑖 , the rate of heat transfer is expressed in the
form
𝑑𝑞
𝑑𝑡

𝜅

= 𝛿 A (𝑇𝑖 − 𝑇)

Equation 1.25
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where, A=area of the growing surface; 𝜅 = thermal conductivity; 𝛿 = effective film thickness for
heat transfer.22
Growth mechanism is known to depend on the type of crystal/melt interface.63 Rough
interfaces are expected for molecules with low entropy of melting (S<2R) while sharp interfaces
for high entropy of melting (S> 4R). Normal or continuous growth corresponds tor rough
interfaces, while lateral growth (spiral dislocation or 2D nucleation) for sharp interfaces. The
General equation or linear growth rate can be represented as
G (T) ∝ 𝐺0 (T) . f . [1 – exp (-ΔG/RT)]

Equation 1.26

where, 𝐺0 (T) ∝ exp (-∆𝐺𝑎 /𝑅𝑇) 𝑎𝑛𝑑 ∆𝐺𝑎 represents the activation free energy associated with
diffusion in the melt; f = depends in the mechanism of growth; [1 – exp (-ΔG/RT)] =
thermodynamic driving force.64
For normal growth, a linear growth increasing with small supercoolings and then decreasing
with lower temperatures is expected. Thus, the maximum for G occurs at a temperature above Tg.
For 2D nucleation lateral growth, the process is only activated when a 2D disc nucleus has been
created. Thus, as compared to normal growth, under this mechanism of growth the Gmax occurs at
a lower temperature and shows a dependence on the interfacial energy associated with forming a
2D nucleus. However, as shown earlier, the nucleation barrier for 2D nucleation is much lower
than that of 3D nucleation, thus the relative positions of Nmax and Gmax do not change.22, 65
The nucleation and growth curves from supercooled melts achieve a maximum at distinct
levels of supercooling. It has been observed that like nucleation, the growth rate increases with
supercooling however, the curve shows a much broader temperature dependence and furthermore,
the growth rate reaches a maximum at a higher temperature than nucleation. This difference in
temperature dependence of Nmax and Gmax is due to the influence of interfacial tension. A high
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value of surface tension leads to a greater nucleation barrier and contributes to Nmax occurring at
a lower temperature.11b, 22
According to Tamman62, the maximum rate of crystallization occurs at a melt temperature, T,
given by
T = 𝑇∗ - (

∆𝐻𝑐𝑟𝑦𝑠
𝑐𝑚

)

Equation 1.27

where, ∆𝐻𝑐𝑟𝑦𝑠 = heat of crystallization, 𝑐𝑚 = mean specific heat capacity of the melt.
The crystal growth rate can be expressed by the following equation
𝑑𝑚
𝑑𝑡

= 𝐾′𝐺 𝐴 (𝑇 ∗ − 𝑇) 𝑔′

Equation 1.28

where, (𝑇 ∗ − 𝑇)= overall temperature driving force; 𝐾′𝐺 = overall mass transfer coefficient;
𝑔′= order of reaction (value between 1.5 and 2.5).22

1.4

Overview of Research

1.4.1 Statement of Problem
In the context of this research, background information provided in earlier sections can broadly
be summarized in two main points:
1.

Cooling a liquid (melt) below its melting point has two possible outcomes: nucleation

and subsequent crystallization or glass formation by passing through Tg.
2.

Glassy solid state is thermodynamically unstable relative to the crystalline state and it

tends to crystallize over time.
Despite numerous challenges, amorphous solid state finds utility in multiple industries –
pharmaceutical, electronic, optical and food. In the pharmaceutical industry, combinatorial
chemistry and high-throughput screening approaches to discover potent drug molecules have
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resulted in many compounds with chemistries that offer poor aqueous solubility.2 While salt
formation has traditionally been employed to increase solubility/dissolution rate, not all
molecules have ionizable functional groups amenable to salt formation.8 Amorphous solid-state
provides an exciting alternative option to modify physico-chemical properties such as solubility
and dissolution rate.11e Therefore, understanding the solid-state chemistry of amorphous drugs
has acquired an important position in solid-state science for the development of solid oral dosage
forms.
While developing an amorphous dosage form, a formulation scientist assesses the impact of
several factors on the performance of the final product. These include but are not limited to:
choice of polymer,66 miscibility,11c, 67 method of preparation (melt extrusion vs. spray drying),51
dissolution profile and stability in solution,11a effect of moisture,11d effect of temperature, and
physical stability under accelerated conditions.68 A thorough investigation of these factors
provides guidance for the final formulation design.
While several of these factors have received attention from the pharmaceutical community,
there is still limited understanding of the inherent ability of a molecule (API) to form a glassy
solid and the relationship between pre-nucleation aggregates and physical stability. The
propensity of a material to vitrify on cooling is referred to as its glass forming ability (GFA).69
Several methods can be employed to transform a crystalline API into a disordered form and have
been discussed in the previous section. One method that is often used in laboratory scale
amorphisation is melt quenching (in DSC or ex-situ). This method acts as a surrogate for the
industrial process of hot melt extrusion. It has been reported that not all API’s can be
transformed into the glassy state with equal ease, with some compounds more predisposed to
form stable glassy solids than others. Furthermore, it has also been noted that despite the
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presence of two distinct Tg’s in a DSC thermogram, certain ASD’s show long-term physical
stability (roundtable at AAPS 2015). Such stability may be linked to the API’s inherent ability to
form a stable glassy phase despite the lack of molecular level miscibility between the drug and
the polymer (as suggested by the DSC data).
Understanding the GFA of an API can help in assessing the risk associated with an amorphous
formulation approach during candidate selection or it can help in choosing a formulation
approach which minimizes such a risk. Furthermore, a better understanding of the molecular
basis of GFA could allow drug discovery scientists to engineer favorable amorphisation
characteristics (ease of formation and stability) into the chemical structure of the organic
molecules at lead optimization stage for a series of bulky highly lipophilic (and potentially
poorly water-soluble candidates) at an early stage and help bridge the gap between “drugability”
and “developability”. Finally, glass formation by melt quenching is a critical parameter for
formulation development by hot-melt extrusion for making amorphous solid dispersions.
A survey of the literature indicates that GFA has been studied using a variety of different
techniques, including but not limited to – determining critical-cooling rates, decoupling in
nucleation and growth curves, viscosity (kinetic fragility) as an parameter for differentiating
between good and poor glass formers, molecular dynamic (MD) simulations to uncover the
underlying atomistic interactions in good glass formers and finally the role of molecular
properties such as hydrogen bonding and conformational distribution. The following paragraphs
provide a snapshot of the literature in this area.
The kinetic theories describing GFA utilize parameters such as the critical cooling rate (CCR)
to predict vitrification potential of organic and inorganic materials. Critical cooling rate is
defined as the minimum-cooling rate needed to restrict crystallized fraction below a pre-defined
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limit.12, 70 Several methods have been specified in the literature for evaluating the critical cooling
rate. The earliest method was developed by Uhlmann, who employed TTT (Time-temperaturetransformation) curves for estimating the fraction of phase crystallized at a given temperature
and time.70 As shown in Figure 1.6, these plots have a characteristic sideways-U shape with the
nose of the plot associated with the highest crystallization rate. This is attributed to the
competition between the thermodynamic driving force for crystallization, which increases with
decreasing temperature, and the decrease in molecular mobility with decreasing temperature.
This method often over-estimates the cooling rates by an order of magnitude when compared to
experimental value.44 TTT curves can be constructed by using calorimetric techniques such as
DSC. Descamps et al. used isothermal DSC experiments to construct TTT curves for L-Arabiol
and using scaling analysis were able to comment on the crystallization mechanism at different
temperatures.71 Due to the difficulty in directly measuring CCR, methods of estimating CCR
have also been developed and specified in the literature. Two such methods by Barandarian and
Colmenero,72 and Cabral73 were applied to organic molecules to estimate the CCR but were
found to be limited in their usefulness for organic pharmaceutical systems.74
Good glass forming ability has also been associated with compounds displaying substantial
differences in the temperature dependence (including the temperature maximum) of nucleation
rate (N) and crystal growth rate (G). Zografi et al. have shown that for indomethacin 
polymorph, the temperature for Nmax occurs at a lower temperature than that for Gmax .75 Thus, as
the sample is cooled below its melting point, a substantial number of nuclei are formed in a
region where the growth rate is extremely slow. This leads to quenching in of the nuclei, which
on re-heating lead to rapid recrystallization. DSC has been used by several research groups to
examine the role of nucleation and growth zones on crystallization from supercooled liquids.65a,
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71, 76

It was observed that on supercooled salol starts to nucleate 40K above its Tg and by using

low-frequency Raman it was shown that the structure of these clusters differs from their
crystalline counterparts.76 A similar DSC analysis was conducted for L-Arabitol and RSIbuprofen, whereby a nucleation zone at a temperature range lower than that for peak growth
kinetics was identified and linked to good glass forming ability.71 In addition, the role of
polymers on crystal growth rates and nucleation has also been evaluated for several small
organic molecules.65
Fragility of a liquid is defined as the sensitivity of the underlying liquid structure to
temperature perturbation. It is experientially evaluated by plotting the temperature dependence of
viscosity (or relaxation time). Liquid fragility has been used to distinguish between good and
poor glass formers.44, 70, 77 The most commonly employed parameter to evaluate liquid fragility is
the strength parameter, D, from the VTF equation (Equation 1.2). Large values of D (D>30) are
observed for strong liquids while low values (D<10) suggest fragile liquids. A value of 7-15 has
been reported for pharmaceutical compounds with good GFA.78 Kim et al. has evaluated the role
of viscosity on glass formation for molecules exhibiting hydrogen-bonding, dipolar interactions
and hindered rotation. D values of less than 10 was reported for all molecules.63 A recent paper
published by Baird et al. evaluated the strength parameter for several drug molecules based of
viscosity data. A D value of less than 10 was observed for all molecules tested in the study,
however, no direct correlation was observed between fragility and GFA.79
In contrast to the theories discussed so far, several studies have investigated GFA based on
atomic or molecular interactions existing in the melt state prior to cooling. Hydrogen bonding
has been identified as playing a key role in amorphisation from melts and has been studied using
spectroscopic and computational methods.80 For 2-biphenylmethanol, the formation of hydrogen-
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bonded tetramers during the vitrification process has been reported and correlated to glass
formation.81 Lebel et al., after examining a group of structurally similar triazine compounds have
suggested that strong intermolecular interactions such as hydrogen bonding can promote
amorphisation by forming aggregates that pack poorly.82 Combining experimental studies with
computation, Habgood et al. have speculated that the presence of two distinct types of hydrogenbonding motifs, which pack poorly, is responsible for the good glass forming ability of
salsalate.80c
In addition, conformational influence on crystallization has been studied for many systems
including sugar alcohols.83 It is reported that sorbitol and iditol retain their glassy state upon
cooling from the melt, while the structurally related mannitol and dulcitol crystallize under
similar conditions.83b, 84 It is suggested that the deterring of sorbitol or iditol crystallization is due
to the presence of different conformers in the melt and the solid state.83a,

84b

Similarly, it is

alluded that the presence of multiple molecular conformers of 2-methyl-1,3-propanediol prevents
its crystallization, while 1,3-propanediol, structurally similar but lacking the methyl group,
crystallizes readily.85
1.4.2 Scientific Approach, Hypothesis and Specific Aims
The literature review presented in the previous section summarizes the different approaches
towards understanding GFA of organic molecules. Current research efforts in this area are geared
towards relating molecular properties to amorphisation potential of a molecule,86 especially to
develop in silico protocols for rapid evaluation of GFA of new drug compounds during early
drug development.86c These studies have examined several molecular descriptors in
understanding vitrification of organic molecules. Properties such as branching of molecular
structure, high number of rotatable bonds and distribution of electronegative atoms in molecules,
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have been positively associated with glass formation, while others such as low molecular weight
and high number of benzene rings have been reported to potentially hinder amorphisation.79, 86a,
86c, 86e

The research discussed in this report focuses on further developing an understanding of the
relationship between molecular structure and amorphisation potential by investigating the
structural elements of a molecule that promote glass formation with high physical stability. A set
of 12 diarylamine compounds selected for this study is shown in Figure 1.7. These compounds
share the same basic diarylamine scaffold but have been substituted at specific locations to study
the role of hydrogen bonding, molecular conformation, and electronegative atoms on
amorphization potential and stability.
Compounds 1-8 are nicotinic acid derivatives (with pyridine ring) while compounds 9-12 are
anthranilic acid analogs (no pyridine ring). Of the nicotinic acid derivative, compounds 1-7 are
alkylated on the phenyl ring, except compound 7, which has a methyl group on the secondary
amine, while compounds 8-11 are halogenated. Compounds 12-15 are fenamic acid, mefenamic
acid, flufenamic acid and tolfenamic acid respectively. Many of these compounds fall in the BCS
Class II. Looking at the molecular structure, two potential hydrogen-bonding interactions are
possible (1-11): carboxylic acid dimer (acid-acid dimer) or the carboxylic acid-pyridine chains
(acid-pyridine).
The primary goal of this research is to develop an understanding of phase transition from
amorphous pharmaceuticals, specifically focusing on the role of thermodynamic, kinetic and
molecular properties of a series of structurally similar compounds. It is hypothesized that the
there exists a link between thermodynamic quantities, kinetic properties, molecular interactions
and glass forming ability. Furthermore, it is hypothesized that the heterogeneity in supercooled
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liquids and glassy state, manifested through intermolecular interactions and conformational
flexibility impacts the observed crystallization behavior.
Understanding the phase transition kinetics and mechanism of crystallization from amorphous
pharmaceuticals is critical for development of stable formulations for drug delivery. The specific
goals of this research include:
.

(1) Investigating the link between thermodynamic and kinetic factors affecting the
crystallization propensity of structurally similar organic compounds from supercooled
liquid state.

.

(2) Evaluating the role intermolecular interactions and conformational distribution on
glass forming ability and stability.

.

(3) Examining the relationship between supramolecular aggregates present in glassy
state and polymorphic outcome.

All model diarylamine compounds have a molecular weight of less than 300 g/mole and show
conformational flexibility between the bridging secondary imine and the aromatic rings. The pKa
of the conjugate acid of pyridine is 5.3, secondary imine is about 10.7, and carboxylic acid is
approximately 4.2.
1.4.3 Dissertation design
In this chapter, fundamentals of nucleation and crystal growth from amorphous state were
described from thermodynamic, kinetic and molecular point of view. Critical factors - such as
fragility, temperature dependence of viscosity, glass transition - which can play a role in devitrification from the amorphous state were examined. A literature review pertaining to
crystallization from amorphous state was presented, highlighting the need to further develop
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greater knowledge in this subject area.
The remaining chapters of this dissertation describe the studies undertaken to complete the
objectives of this research. The second chapter examines the relationship between
thermodynamic and kinetic properties affecting crystallization from amorphous state. A
fundamental relationship was sort between entropy of fusion, melt viscosity and glass forming
ability. The third chapter investigates the role of intermolecular interactions, particularly
hydrogen bonding, on crystallization kinetics from supercooled liquid state using spectroscopic
techniques. The fourth chapter involves examining the relationship between supramolecular
aggregates embedded in the glassy state and the polymorphic outcome. This chapter provides an
insight into the structure of amorphous state and offers suggestions for selecting excipients for
preventing crystallization. The final chapter provides an overall summary of the research
presented in this dissertation.

37

Figure 1.1. (a) Enantiotropic system (b) Monotropic polymorphic pair (I and II). H is the
enthalpy, G is the Gibbs free energy and T is the temperature. Subscripts t, m and liq refer to
transition, melting temperature and liquid state, respectively.16
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Figure 1.2. Concentration vs. Temperature phase diagram used for process development of
cooling crystallization.22
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Figure 1.3. Illustration of the supercooled liquid and glassy region separated by the glass
transition temperature (Tg).41
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Figure 1.4. Behavior of heat capacity on supercooling.78
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Figure 1.5. Graphical representation of the thermodynamics of nucleation as
described under CNT.22
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Figure 1.6. Graphical representation of a typical time-temperature-transformation (TTT) diagram
and the critical cooling rate (Rc).69
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Figure 1.7. Chemical structures of compounds examined in this study. The primary torsion
angles for these compounds are specified for compound 1.
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CHAPTER 2.

GAINING THERMODYNAMIC INSIGHT FROM

DISTINCT GLASS FORMATION KINETICS OF STRUCTURALLY
SIMILAR ORGANIC COMPOUNDS

2.1

Abstract

Studying the physical stability of pharmaceutical compounds in the amorphous phase
(supercooled and glassy state) has become increasing important as a result of the temporary
solubility advantage afforded by this non-crystalline state. The vitrification tendency of a
molecule from the supercooled liquid state, defined as its glass forming ability (GFA), helps in
assessing the crystallization risks associated with an amorphous formulation. Herein,
thermodynamic and kinetic aspects of crystallization of 12 structurally similar organic
compounds were investigated from the supercooled liquid state by calorimetric and rheological
measurements. Based on their crystallization behaviors, these compounds were divided into three
categories: stable glass formers, poor glass formers, and good glass formers with poor stability
on reheating. Correlation was sought between thermodynamic quantities – enthalpy of fusion
(∆Hfus), melting point (Tm), driving force for crystallization (∆Gv), entropy of fusion (∆𝑆fus) –
and glass formation based on nucleation and crystal growth theories. On average, larger values of
∆Hfus and Tm were found to correlate with poor GFA. As anticipated, a lower driving force for
crystallization (∆Gv) was observed for good glass formers. Interestingly, lower entropy of fusion
(∆𝑆 fus) was found to correlate with glass formation, in contrast to the prediction of classical
nucleation theory (CNT). Examination of kinetic aspects of glass formation revealed two
important facets of good glass formers: rapid increase in viscosity on supercooling and high
melting-point viscosity (melt) as compared with non-glass formers. A linkage between
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thermodynamic ( ∆𝑆 fus) and kinetic (melt, reduced glass transition temperature) factors was
explored, highlighting the capability of thermodynamics to impact the observed crystallization
kinetics. Furthermore, a broader relationship was sought between ∆𝑆fus and glass formation by
examining several glass formers from literature. Based on this analysis it is proposed that good
glass formers tend to have a ∆𝑆fus closer to 30 X 10-2 J/(cm3 K-1). Lastly, the structural similarity
of the compounds in this study provides insights regarding the nature of intermolecular
interactions responsible for the observed effect on ∆𝑆fus, viscosity and crystallization kinetics.

2.2

Keywords

Pharmaceuticals, glass forming ability, crystallization, amorphous, supercooled liquids,
amorphous solid dispersions.

2.3

Introduction

Crystallization is one of the most investigated phenomena in chemistry and materials science.
Despite extensive research, molecular mechanism of crystallization, especially nucleation,
remains enigmatic. There has been considerable interest in understanding crystallization
propensity and mechanism from the amorphous state (supercooled liquids and glassy).87 In drug
development, amorphization is an important formulation strategy to enhance the apparent
solubility and dissolution rate of poorly water-soluble drug compounds. The favorable attributes
of the amorphous state result from the excess thermodynamic quantities such as enthalpy,
entropy and free energy, which manifest as a lower energy barrier for drug molecules to enter the
solution phase. However, this higher energy state combined with enhanced molecular mobility
(with respect to crystalline state) often leads to poor physical stability and eventual
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crystallization.11b To alleviate this shortcoming, polymers are often employed to kinetically
stabilize the amorphous drug.11f, 66, 88 Several studies have been conducted to assess the impact of
critical factors on the performance of the final product, including choice of polymer,11f, 66, 88
drug-polymer miscibility,11c,

67

method of preparation,89 dissolution profile and stability in

solution,11a and physical stability under accelerated conditions of temperature,11d pressure,14, 90
and moisture.91 Despite the efforts, the ability of an active pharmaceutical ingredient (API) to
transform to a glassy state is not well understood. A greater comprehension of amorphization
potential and stability of an API during early drug development can help in assessing the stability
risk associated with an amorphous formulation, and determine the amount and type of polymer
to stabilize the amorphous drug.10, 92
The propensity of a material to vitrify on cooling is defined as its glass forming ability
(GFA).12, 73 Crystallization from the amorphous state has been studied by examining numerous
parameters derived from thermodynamic and kinetic properties. Based on configurational
thermodynamic properties and calculated molecular mobilities for a group of structurally diverse
compounds, it was found that compounds with high configurational entropy and low molecular
mobility display the greatest resistance to crystallization in the supercooled liquid state. 93
Because configurational entropy approaches zero at a temperature 50 ° C below Tg (glass
transition temperature), storage of amorphous samples below this temperature is expected to
impede crystallization.11b However, crystallization well below Tg was nonetheless observed.94
Furthermore, compounds with similar Tg were shown to display different degrees of stability,
which was correlated with the configurational enthalpy component of the free energy change of
crystallization.95 Using principal component analysis (PCA) and contribution plots,
physiochemical and thermodynamic properties were used to distinguish good glass formers from
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poor glass formers for a diverse set of pharmaceutical compounds. It was observed that high
molecular weight (MW) correlated with good GFA, while poor glass formers displayed high
enthalpy and entropy of fusion (as compared to good glass formers).87a
Kinetically, GFA is often rationalized on the basis of mass transport processes involved in
crystallization. Several parameters (such as critical cooling rate (CCR) and reduced glass
transition temperature (Tg/Tm)) were introduced to estimate the vitrification potential of
materials.73,

87e, 96

Differential scanning calorimetric (DSC) based methods were successfully

used to estimate these parameters for inorganic systems.72 However, unlike inorganic systems,
no correlation was observed between glass formation and these parameters for molecular
pharmaceuticals.87a CCR is one of the most important experimental parameter in estimating GFA
and is defined as the minimum-cooling rate required to vitrify a molten compound. Timetemperature-transformation (TTT) curves built from DSC measurements are used to estimate
CCR and typically display a characteristic nose-shape.69, 97 This is ascribed to an increase in
thermodynamic driving force for crystallization and decrease in molecular mobility on
supercooling. Molecular mobility, described by the translational and rotational motions of
molecules, is often evaluated by measuring molecular relaxation time and viscosity.94 Parameters
derived from examining the temperature dependence of viscosity (or relaxation time) are used to
distinguish good glass formers from poor glass formers. One such property is liquid fragility and
is defined as the sensitivity of the underlying liquid structure to temperature perturbation. 82c, 87e
Strength parameter (D) and fragility parameter (m), which describe liquid fragility, show
correlation with glass formation.98 A direct correlation between melt viscosity and GFA is also
been reported in the literature.87e, 99
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Glass formation shows extensive variation among pharmaceutical compounds.87a These studies
typically relied on several compounds with diverse molecular structures, which limits detailed
assessment of the contribution of functional groups and their interactions to vitrification.
Therefore, the objective of this study was to investigate the role of thermodynamic and kinetic
properties on glass formation of a set of structurally similar pharmaceutical compounds and
identify the relationship between these properties on crystallization tendency above T g. A
combination of thermal (thermodynamic) and rheological (kinetic) analyses was utilized to
evaluate the impact of these macroscopic properties on GFA. The 12 diarylamine compounds
selected for this study are shown in Scheme 1. These compounds share the same diarylamine
scaffold but with functional groups at specific locations in order to identify the role of molecular
structure on vitrification potential. This study was also aimed at developing greater
understanding of why seemingly structurally similar compounds display strikingly different
performance properties as amorphous materials.

Many of these compounds show

pharmacological activity as non-steroidal anti-inflammatory drugs (NSAIDs).

2.4

Materials

Compounds 1-6 and 8 were synthesized in our laboratory.100 Compounds 7 (98% purity), 9
(98% purity), 10 (98% purity), 11 (98% purity) and 12 (97% purity) were purchased from TCI
America (Portland, OR). Ethanol (200 proof) was obtained from Decon Labs (King of Prussia,
PA). Methanol, acetone, hexane, toluene, ethyl acetate, chloroform, dichloromethane were
obtained from Macron (Center Valley, PA). Dimethyl sulfoxide (DMSO-d6) was obtained from
Cambridge Isotope Inc. (Tewksbury, MA).
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2.5

Methods

2.5.1 Synthesis of compouds
Synthetic schemes for diarylamine compounds 1-2 and 4-8 were reported previously in the
literature.100 The series was further expanded by synthesis of compound 3. The purity of the
synthesized compounds was ensured by re-crystallization and examining the retrieved sample by
solution NMR spectroscopy (and PXRD), with all compounds showing >98% purity.
2.5.2 Solution NMR spectroscopy
A Bruker DRX500 (5 mm BBFO Z-gradient probe; Topspin 1.3 software) NMR spectrometer
was used to verify the chemical structures and purity of the synthesized compounds. Thermal
stability of the synthesized compounds was evaluated by visual inspection (absence of charring)
and solution NMR spectroscopy as well. Compounds 9-12 have been shown to possess thermal
stability during DSC experiments in a previously published study.101
2.5.3 Powder X-ray diffraction
Polymorphic forms of the compounds were verified by PXRD. A Rigaku Smartlab
diffractometer (in the Bragg-Brentano setup) with Cu K radiations (40kV, 40mA) was used for
data collection. Diffraction patterns were collected between 4.0° and 40.0° 2𝜃. A step size of
0.02° at room temperature was employed during the experiments.
2.5.4 Differential scanning calorimetry (DSC)
A Q20 differential scanning calorimeter (DSC) (TA instruments, New Castle, DE) equipped
with a liquid nitrogen cooling system (LNCS) was used to determine the crystallization tendency
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of the compounds from the melt state. An indium standard was used to calibrate the temperature
and heat flow by measuring the onset temperature and enthalpy response. A constant purge of
helium gas at 25 mL/min was used during the experiments. Samples were hermetically sealed in
Tzero® aluminum pans/lids and heated at 10 °C/min to approximately 2-5 °C above the melting
offset. The samples were cooled at the rate of 40 °C/min to ˗40 °C, and then reheated again
above the melting temperature at 10 °C/min.
2.5.5 Viscosity Measurement
AR 2000 Ex rheometer (TA instruments, New Castle, DE) was used to measure the viscosity
of supercooled liquid state. The measurement system consisted of a 8 mm parallel plate
geometry made of stainless steel. An environmental test chamber (ETC) heating accessory with a
heating range of -160 °C to 600 °C and a constant purge of nitrogen was used to transfer heat
from the heating coils to the sample by convection. Prior to use, the system was calibrated for
instrument inertia, geometry inertia and the gap between the upper and lower geometry.
Sample preparation involved compaction of 6 mm diameter disks of the sample powder using a
Carver press. Sample compacts were placed onto the lower plate at room temperature and then
the sample was melted. Gap width was adjusted by lowering the upper plate, and the
temperatures of the system was allowed to equilibrate. Then, the temperature was lowered to the
melting point and viscosity data collected in the rotational mode. Next, the temperature was
raised to re-melt the sample and then cooled to a lower temperature to measure the viscosity. The
same procedure was repeated until the sample crystallized.
2.5.6 Statistical Analysis
Student’s t-test was done using OriginPro Version 9.1 with the significance level set at p<0.05.
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2.6

Results

2.6.1 Crystallization and characterization of polymorphic forms
The polymorphic forms obtained after crystallization of synthesized compounds are
summarized in Table 2.1. Various crystallization methods (cooling crystallization, evaporative
crystallization and being collected after synthesis) were adopted for polymorph screening with
the objective of identifying and obtaining the most stable polymorph for thermal analysis.
Furthermore, exploring the polymorphic diversity of each compound allows analysis of
crystallization products, if seen, during DSC experiments. The polymorphic forms obtained were
verified by comparing the experimental powder X-ray diffraction spectra with the simulated
spectra generated from single crystal structures of the respective compounds.
Compound 1 (2PNA) has four polymorphic forms – 100a  polymorph is the
thermodynamically most stable form at room temperature and is readily obtained by
crystallization from ethanol. The  polymorph was obtained by slowly cooling the reaction
mixture during compound synthesis.  polymorph converts readily to the  polymorph in
solution by solvent mediated phase transition.  and  forms could not be obtained by solution
crystallization. 2 and 4 have only one polymorphic form reported in the literature and were
obtained by crystallization from acetonitrile and methanol, respectively.100c 3 was subjected to a
polymorph screening using a variety of solvents. A new form was obtained from ethanol and the
crystal structure was solved. The polymorph belongs to P21/n space group and consists of one
symmetry independent molecule in the asymmetric unit. Analysis of crystal packing will be
published elsewhere.
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Compounds 5 and 6 have one reported polymorph each and were obtained by crystallization
from ethanol.100d 7 (clonixin) has four reported polymorphs – I, II, III and IV.102 While forms I,
III and IV are neutral, polymorph II is zwitterionic. Polymorph I was provided by the supplier,
polymorph III was crystallized from dichloromethane, and finally Form IV was obtained by
storage of amorphous clonixin (prepared by melt quenching in liquid nitrogen) for 20 days in a 0%
relative humidity (RH) chamber. Form I is the most stable form at room temperature and is
enantiotropically related to forms III and IV.103 8 has four reported anhydrous polymorphs – I, II,
III, IV – and one monohydrate form.100b The monohydrate form was obtained from the synthetic
mixture. Form I, the most stable form, was obtained from a mixture of hexane and ethyl acetate
(50:50) and used for the subsequent experiments.100b
Compound 9 (fenamic acid) has only one crystal structure reported in the literature.104 10
(flufenamic acid) is one of the most polymorphic compounds with eight reported crystal
structures.105 The form provided by the supplier was identified as Form I and was used as such.
11 (mefenamic acid) has three reported polymorphs – I, II and III.17 At room temperature, form I
is the most stable form and was provided by the supplier.17 12 (tolfenamic acid) has five reported
crystal structures but only two polymorphs are commonly encountered.106 Form I (colorless) was
provided by the supplier and Form II (yellow) was crystallized from rapid cooling of a
supersaturated ethanol solution. Form I is reported as the most stable form107 and was used in
this study.
2.6.2 Thermal evaluation of glass forming ability
To examine their glass forming ability and stability, DSC was utilized to measure the thermal
properties of the model compounds, including melting point (Tm), glass transition temperature
(Tg) and heat of fusion (Hfus). Phase transitions, such as crystallization, are known to be
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affected by the cooling rate employed during experiment, with rapid cooling rates often
precluding re-crystallization events.87a, 108 The purpose of using the aforementioned DSC method
was to compare these structurally similar compounds under identical conditions. These DSC
experiments utilized a moderate cooling rate of 40 °C/min. To further examine the effect of
higher cooling rate, the melts were quenched with liquid nitrogen and the resulting samples were
examined using DSC.
On cooling from the melt state, compounds 1, 2, 3, 4, 6, 8 and 10 did not crystallize and
formed glassy solid. On reheating the glassy phase, 3, 4, 8 showed no re-crystallization event and
remained amorphous with respective Tg values of 38.3, 49.9 and 27.1 ° C (Figure 1.1C).
Conversely, 1, 2, 6 and 10 showed exothermic crystallization peaks in the supercooled liquid
region (Figure 2.1A). For 2, 6 and 10, the melting point of the re-crystallized solid was identical
to that of the starting material; the recrystallized solid of 1 showed a different melting point to
the starting material  polymorph). The recrystallized solid was confirmed as the  polymorph
based on the reported melting point of 143.7 °C.100a 5 and 7 (clonixin) crystallized under the
moderate cooling rate accessible with DSC but could be vitrified on quenching with liquid
nitrogen (Figure 2.1B). The Tg (midpoint) was identified as 38.6 and 50.8 °C, respectively. Both
compounds re-crystallized on re-heating. For 5, the re-crystallized solid was identified as a new
polymorph using PXRD and DSC. Similarly, 7 (clonixin) crystallized as Form IV before
showing a solid-solid phase change. The average Tg (midpoint) of these glass forming
compounds is 43.8 °C ± 14.3 °C.
Finally, compounds 9, 11 and 12 crystallized at moderate cooling rate in the DSC (Figure
2.1D) with re-crystallization peaks observed at 156.2, 120.5 and 143.9 ° C, respectively.
Recrystallization was observed even during melt quenching with liquid nitrogen. 11 (mefenamic
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acid) showed a phase transition from Form I to Form II at 174 °C before form II melted at 230.7
°C. The inability to form the glassy state of 12 (tolfenamic acid) has been reported previously
(using melt quenching, spray drying, and cryomilling) in the literature.87a, 87d
The compounds were categorized based on the classification scheme employed by Taylor and
co-workers.87a According to this system, compounds can be categorized into three groups based
on their phase behaviors under a heat/cool/heat DSC protocol: Class I – crystallize on cooling
from their melt state (further classified as Class IA – crystallize on cooling with rapid cooling
with liquid nitrogen and in DSC or Class IB – can be vitrified on rapid cooling with liquid
nitrogen but not with moderate cooling rates employed in DSC); Class II – these compounds
form the amorphous glassy state on cooling their melt but crystallize on re-heating; Class III –
these compounds do not crystallize on cooling or re-heating. The results based on this
classification are summarized in Table 2 and are used to discuss the viscosity data in the next
section.
2.6.3 Viscosity Measurements
Viscosity is a macroscopic property which represents the resistance to flow. It characterizes the
kinetic barrier to the transport of growth units (molecules) and can impact the crystallization
behavior on cooling from the melt state. In this section, the role of viscosity on the vitrification
potential of the model compounds was studied.
From the 12 compounds evaluated in this study, 8 compounds were subjected to steady state
rheometery to measure their shear viscosity () as a function of degree of supercooling (Tm - T).
The shear rate of 10 Hz was selected because it ensured constant viscosity measurement over
time. Any change in viscosity observed with supercooling at this shear rate thus reflects the
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effect of changing material properties. The results plotted as a function of degree of supercooling
are shown in Figure 2.2.
Four Class I molecule - 5, 9, 11 and 12 - were subjected to viscosity measurement (Figure
2.2A). Compounds 9, 11 and 12 are rapid crystallizers with poor glass forming ability. While it
can be supercooled to around 10 °C in a DSC pan, under the shearing conditions of a rheometer
the molten sample could not be supercooled without initiating heterogeneous nucleation and
crystallization. The average melt viscosity of these compounds was recorded as 6.3 X 10-2 Pa ∙ s.
5, the fluorinated compound, was selected to represent Class IB. This compound crystallized
during the DSC experiments but could be amorphized on quenching its melt with liquid nitrogen.
As expected, with decreasing temperature, an increase in the viscosity was observed (Figure
2.2A). A supercooling of 20 °C could be achieved before crystallization. The melt viscosity of
the compound was recorded as 9.5 X 10-2 Pa ∙ s. This value is higher than that for the Class IA
compound tested under identical conditions. The shear viscosity value increased to 24.2 X 10 -2
Pa ∙ s at a supercooling of 20 °C that is 2.5 times the melt viscosity.
Two Class II compounds, 1 and 2, were evaluated to uncover the role of viscosity in promoting
glass formation. These compounds form amorphous glasses on cooling at moderate cooling rates
and exhibit similar viscosity behavior as a function of supercooling (Figure 2.2B). 1 and 2 could
be supercooled to 20 °C and 35 °C below the melting point before crystallization. The melt
viscosities of 1 and 2 were recorded as 14.0 X 10-2 and 21.0 X 10-2 Pa ∙ s, respectively. For 2, the
viscosity at a supercooling of 35 °C was recorded as 2.1 Pa ∙ s, an order of magnitude greater
than its melt viscosity. Similarly, for 1, the relative change in viscosity at 20 °C of supercooling
is 5 times.
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Class III compounds 3 and 4, are extremely robust glass formers that remain stable on reheating. A sharp increase in shear viscosity was observed with decreasing temperature (Figure
2.2C). The melt viscosities of 3 and 4 were recorded as 50.0 X 10-2 and 22.0 X 10-2 Pa ∙ s,
respectively. Unlike Class II compounds, these compounds could be supercooled to temperatures
close to their glass transition temperatures during the viscosity measurement. The relative
increase in viscosity for 3 and 4 at 60 °C of supercooling was 2754 and 101 fold respectively,
which are several orders of magnitude greater than those seen for Class I/II molecules.
These results point to the fact that compounds with greater glass forming ability have higher
melt viscosities, while rapid crystallizers tend to have relatively lower viscosity values (Figure
1.2D). These results are in agreement with those observed in a similar study conducted by Baird
et. al.87e Furthermore, Class I compounds that were studied here have a melt viscosity below 10.0
X 10-2 Pa ∙ s., while both the Class III compounds have melt viscosities greater than this
threshold value. As expected, Class II compounds have intermediate viscosity values.

2.7

Discussion

The organic molecules examined in this study exhibit distinct phase behaviors despite the
similarity in chemical structure. The compounds can be placed in three categories based on their
crystallization tendency - Class I molecules showing poor GFA, Class III good GFA and stability,
while Class II compounds show good GFA with poor stability on reheating.87a Table 2.2
summarizes the phase behaviors of the structurally similar compounds.
Crystallization from the melt state involves nucleation and crystal growth. The kinetics can be
described by the steady-state nucleation rate (J) and crystal growth rate (I) as presented in
Equations 1 and 2, respectively. In the equations, Jo is the pre-exponential factor, ∆𝐺𝜂 represents
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the kinetic barrier to nucleation, 𝜂 is the viscosity of the supercooled melt, 𝛾 is interfacial energy
of the nucleus-melt interface, kb is Boltzmann constant, T is the temperature, f is the number of
sites on the interface for molecular addition or removal, and L represents the distance progressed
by the interface.22, 109
According to Classical Nucleation Theory (CNT), for a spherical nuclei, J is dependent on the
thermodynamic barrier for nucleation (∆𝐺𝑐𝑟𝑖𝑡 ), which itself shows an inverse relatioship to the
free energy difference between the melt and crystalline states per unit volume (∆𝐺𝑣 ) as shown in
equation 2.3.22, 110 According to the screw dislocation model (Equation 2.2), I shows a similar
dependence on ∆𝐺𝑣 .111
𝐽 = 𝐽0 𝑒𝑥𝑝[ −
I=f

𝑘𝐵 𝑇
𝐿2 𝜂

∆𝐺𝑐𝑟𝑖𝑡 + ∆𝐺𝜂
𝑘𝐵 𝑇
∆𝐺

[ 1- exp (𝑘 𝑇𝑣 ) ]
𝐵

16 𝜋 𝛾3

∆𝐺𝑐𝑟𝑖𝑡 = 3 (∆𝐺

2
𝑣)

]

Equation 2.1
Equation 2.2
Equation 2.3

Thus, a better glass former is expected to have a lower thermodynamic driving force for
crystallization (∆𝐺𝑣 ). Additionally, a greater interfacial energy per unit area (𝛾) also supports
greater stability of the undercooled melt against crystallization.
The difference in the average thermal and thermodynamic properties (Tm, Tg, ∆𝐻fus, ∆𝑆fus, ∆𝐺𝑣 )
of Class I, II and III compounds are shown are Figure 2.3. ∆𝐻fus, ∆𝑆fus, and ∆𝐺𝑣 were converted
to a volume basis by multiplying the weight-based values by the crystalline density (Table
2.3).11b, 87a The free energy difference between the crystalline and amorphous states (∆𝐺𝑣 ) was
estimated using the Hoffman approximation to determines the driving force for crystallization.11b
As expected, a more negative value is obtained for Class I compounds (-42.4 ± 5.7 J/cm3) as
compared with Class III (-23.2 ± 4.2 J/cm3) (p-value = 0.00258). Higher values of ∆𝐻fus and Tm
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indicate greater strength of intermolecular interactions and consequently greater stabilization on
crystallization. As expected, the rapidly crystallizing Class I compounds display greater values
(∆𝐻fus = 182.1 ± 18.0 J/cm3; Tm = 477.9 ± 34.1 K) than Class III compounds (∆𝐻fus = 115.2 ±
22.8 J/cm3; Tm = 417.0 ± 21.1 K). The difference was statistically significant with a p-value of
0.00359 and 0.03386, respectively.
The role of ∆𝑆fus on glass formation requires greater examination. The entropy of fusion (∆𝑆fus)
was obtained by dividing the heat of fusion with the melting onset temperature (Table 2.3).
According to CNT, the steady state nucleation rate decreases with increasing ∆𝑆fus (Equation 4)
𝑏 𝑁 𝑉 2 𝛾3 ∆𝑆𝑓𝑢𝑠

𝐽 = 𝐽0 𝑒𝑥𝑝[ − (∆𝐻

𝑓𝑢𝑠)

3

∆𝑇 2 𝑇 𝑅

]

Equation 2.4

where, b is a constant determined by nucleus shape, N is Avogadro’s number, V is the molar
volume of the crystal, R is gas constant, T is defined as T/Tm and ∆𝑇 is defined as (Tm-T)/Tm.112
This suggests that higher values of ∆𝑆 fus would favor glass formation by decreasing the
nucleation rate, J. However, it has also been suggested that formation of locally favored
structures in the melt and supercooled liquid state can reduce ∆𝑆fus and thus, a lower value of
∆𝑆fus would correlate with good glass formers.113 The latter has been observed for metallic glass
formers.114 In our study, on average, a lower ∆𝑆fus was observed for good glass formers ((27.7 ±
6.1) X 10-2 J/(cm3.K)) as compared with rapid crystallizers (38.1 ± 3.2) X 10-2 J/(cm3.K)). The
difference was statistically significant with a p-value of 0.01856. This may be associated with
hydrogen-bonded aggregates present in the melt state (See later in Discussion).
Several empirical parameters are mentioned in the literature to describe the GFA of a
material.12, 112 One such kinetic parameter is reduced glass transition temperature (Trg = Tg/Tm)48,
112

and is reported for our compounds in Table 2.3. For the molecules whose Tg could not be

experimentally determined, the value was estimated from a plot of Trg versus molecular weight
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(g/mol), based on an established literature method.87a A Trg close to 1 indicates a greater GFA
because the smaller gap between Tg and Tm results in a rapid increase in viscosity on cooling
with reduced mobility for the molecules to organize into a crystal structure. Such behavior is
observed for the compounds studied here with Class III and I, displaying an average T rg of 0.75 ±
0.02 and 0.68 ± 0.04 (p-value = 0.03602), respectively, commensurate with their observed
crystallization behaviors.
The kinetic aspect of glass forming ability was further explored by measuring viscosity of the
model compounds (Table 2.3). The role of melt rheology on glass formation can be understood
from the influence of viscosity (𝜂) on nucleation and growth kinetics. Both nucleation and
growth rates are inversely related to viscosity, as seen from Equations 1 and 2.22 Thus, a higher
melt viscosity is expected for compounds displaying good GFA because a rise in viscosity
provides a greater barrier for molecular motion required for crystallization. As seen in Figure 2D,
the average viscosity of Class I (4.2 X 10-2 Pa ∙ s), II (18.2 X 10-2 Pa ∙ s) and III (36.6 X 10-2 Pa ∙ s)
demonstrate the anticipated trend.
From the results discussed above, the thermodynamic parameters including ∆𝑆fus and ∆𝐺𝑣 can
be correlated to glass formation. Similarly, the ability of melt viscosity (𝜂𝑚𝑒𝑙𝑡 ) and reduced glass
transition temperature (Trg = Tg/Tm) to differentiate between good and poor glass formers is also
observed. The relationship between kinetics and thermodynamics is further examined by plotting
log 𝜂𝑚𝑒𝑙𝑡 and Trg as a function of ∆𝑆fus. Data for the model compounds examined in this study
along with those from the literature87e are plotted and shown in Figure 2.5. A roughly linear trend
seems to exist between log 𝜂𝑚𝑒𝑙𝑡 and ∆𝑆fus as well as Trg and ∆𝑆 fus. On average, a high melt
viscosity corresponds to lower thermodynamic entropy of fusion and vice versa (Figure 2.5A).
Furthermore, Class I compounds (rapid crystallizers) demonstrate the lowest melt viscosity and
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the highest entropy of fusion. On the other hand, Class III compounds (good GFA) exhibit the
opposite behavior. Reduced glass transition temperature (Trg), proposed by Turnbull on the basis
of crystal nucleation and growth theory,112 shows a similar relationship (Figure 2.5B). As pointed
out earlier in the discussion, a higher value of Trg indicates a greater glass forming ability.
Overall, compounds with higher Trg show lower entropy of fusion and belong to Class III.
Compounds with lower Trg demonstrate higher ∆𝑆fus and are rapid crystallizers (Class I). This
analysis reflects the importance of ∆𝑆fus on glass formation and crystallization kinetics.
∆𝑆 fus is a critical quantity in controlling the kinetic behavior of materials. 99, 101, 109 This is
evident from its influence on nucleation rate112 and crystal growth rate.109 In our study, it has
been observed that good glass formers display lower entropy of fusion than poor glass formers.
To examine the generality of this observation, the entropy of fusion of 60 compounds (12 from
this study along with 48 from reference 87a) was examined (Figure 2.6). The black bars show the
∆𝑆 fus frequency histogram for all 60 compounds. The compounds can be divided into three
groups: (I) ∆𝑆fus < 30 X 10-2 J cm-3 K-1, (II) 30 X 10-2 J cm-3 K-1 < ∆𝑆fus < 45 X 10-2 J cm-3 K-1
and (III) ∆𝑆fus > 45 X 10-2 J cm-3 K-1. Ten compounds are in the first group, 38 in the second and
9 in the third. In order to identify the relationship between entropy and glass forming ability, the
compounds were plotted based on their crystallization tendency segregated into Class I (red bars),
II (green bars) and III (purple bars) compounds. It can be seen that 7 of the 9 group III
compounds belong to Class I. Only two compounds – lidocaine of unusually low heat of fusion
and caffeine of high Tm – have entropy less than 30 X 10-2 J cm-3 K-1. Conversely, 8 of the group
I compounds belong to Class III, with the rest having entropy between 20 X 10-2 and 45 X 10-2 J
cm-3 K-1. Most of the Class II compounds belong to group II with only 2 compounds having
entropy greater than > 45 X 10-2 J cm-3 K-1.
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These results highlight the correlation between entropy of fusion and glass formation. Good
glass formers (Class III) tend to have lower entropy than rapid crystallizers. On average, Class I
compound have a ∆𝑆fus of 41.05 X 10-2 ± 8.7 J cm-3 K-1, while Class III compounds have a ∆𝑆fus
of 31.33 X 10-2 ± 7.04 J cm-3 K-1. While there are few outliners (and the number of compounds
is limited) it can be concluded that good glass formers will have ∆𝑆fus closer to 30 X 10-2 J cm-3
K-1 than 40 X 10-2 J cm-3 K-1. For the 12 structurally similar compounds, analyzed in this study,
as are often encountered at the interface of drug discovery/development in the pharmaceutical
industry, this has been observed.
Another important aspect of this analysis is the use of volumetric units - J cm-3 K-1 - to
describe entropy. While entropy is usually represented by J/(mol.K) units, these units are
converted to the volumetric units by normalizing for molecular weight (MW) and then
multiplying by the crystalline density. MW is known to be an important descriptor for
differentiating good from bad glass formers.87a,

87d

A MW>300 g/mole has been positively

correlated with glass formation.86c In examining the aforementioned 60 compounds, it was
observed that the average molecular weight of Class III compounds was 379 .3 ± 146.4 g/mole,
which is higher than that observed for Class I compounds, 222.5 g/mole ± 60.3 (Figure 2.7).
Normalizing by MW allows the entropy for different compounds to be compared on per atom
basis, thereby compensating for the entropy difference arising because of different size of the
molecules. Such an approach to account for different molecular sizes in comparing
thermodynamic quantities has been reported in the literature.115 Accordingly, the higher MW, on
average, for glass formers leads to a smaller volumetric entropy (considering that the range of
crystalline density for organic crystals is fairly narrow; 0.6 g/cm3 for these compounds).
Entropy of fusion (∆𝑆fus) can be described as the summation of
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∆𝑆fus = ∆𝑆h+∆𝑆ot+∆𝑆conf

Equation 2.5

where, ∆𝑆h is the enthalpic component of entropy, ∆𝑆ot is the entropy gained due to increase in
translation and orientation motion on melting, and ∆𝑆 conf is the conformational entropy for
flexible molecules.116 As already discussed earlier, glass formers have lower enthalpy of fusion
than rapid crystallizers, which translates into a lower ∆𝑆 h and thus lower overall entropy.
Furthermore, the overall entropy of glass formers could be lowered by formation of hydrogenbonded aggregates, which restricts translational/orientation motion as well as conformational
flexibility, thereby lowering ∆𝑆ot and ∆𝑆conf, respectively. It has been reported that low ∆𝑆fus of
good glass formers is associated with formation of locally favored structure in the
melt/supercooled state.114 These structures are responsible for the stability of supercooled liquids
and reduce liquid entropy. The formation of icosahedral motifs in multicomponent metallic
supercooled liquids was associated with the reduction of its ∆𝑆fus.113a, 117 Similarly, for organic
molecules, the presence of strong hydrogen-bonding interactions has been known to lower
∆𝑆fus.116 Figure 2.8 summarizes the hydrogen-bonding motifs that can be formed by the model
compounds in this study. It can be seen that compounds belonging to Class III possess acidpyridine synthon in all known crystal structures, while Class I compounds can only assemble
into crystalline lattice with carboxylic acid dimers as the building unit. This behavior is
exemplified by comparing the chemical structures of 1 and 9. These two compounds exhibit
drastically different phase behaviors but are only distinguished by the presence of a pyridine ring
nitrogen. Thus, the ability to form the acid-pyridine motif and possible hydrogen-bonded chains
leads to higher local ordering in the supercooled melt state, which appears to contribute to low
∆𝑆fus and high melt viscosity. Another important observation pertains to the compounds that recrystallize on re-heating (such as compounds 1, 2 and 5). From the polymorph assessment done
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earlier, it was observed that these compounds are capable of forming crystal structures with acidacid synthon. Further assessment of the molecular mechanism involved will be published
elsewhere.
Both thermodynamics and kinetics contribute to the observed phase behaviors of these
compounds. There is no doubt that a supercooled liquid will eventually recrystallize. The free
energy advantage dictates the ultimate outcome of any phase transition. Yet, kinetic factors
manifested through molecular motion and alignment characterizes the disparity of how fast or
slow a metastable state can transit into the stable crystalline state. By utilizing a series of
structurally similar compounds this study permits a closer look at how molecular structure
underlies the thermodynamic and kinetic factors affecting crystallization.

2.8

Conclusions

Crystallization behaviors of 12 structurally similar organic compounds from the supercooled
melt state were studied by inspecting their thermodynamic and kinetic properties. The
compounds were categorized into good and poor glass formers based on the phase behavior
observed on melt quenching. Thermodynamic quantities - Tm, ∆𝐻fus, ∆𝑆fus, ∆𝐺𝑣 – can be used to
understand the observed differences in the phase behavior of these compounds. Furthermore,
good glass formers display a higher melt viscosity, a kinetic property, plays a dominant role in
influencing the crystallization kinetics of these compounds. A roughly linear trend between ∆𝑆fus
and 𝜂𝑚𝑒𝑙𝑡 (also Trg) seems to exist, highlighting the interplay between thermodynamics and
kinetics in understanding the crystallization from supercooled melt state. Further investigation of
∆𝑆fus, it has been observed that good glass formers display lower entropy of fusion than rapid
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crystallizers. Entropy of fusion is easily determined experimental parameter and provides a
pharmaceutical scientist with the ability to judge the glass forming ability of a set of structurally
similar compounds at the interface of drug discovery and development. It is proposed that good
glass formers would tend to have ∆𝑆fus closer to 30 X 10-2 J/(cm3.K) than 40 X 10-2 J/(cm3.K).
For those compounds crystallizing from the melt state upon cooling, the crystal structures
possess the carboxylic acid dimer synthon. For those forming a glass, the compounds form
carboxylic acid-pyridine synthon. The phase behavior differences in this set of structurally
similar molecules suggests that intermolecular hydrogen-bonding arrangements in the melt plays
a key role in determining the glass forming ability of these molecules.
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Figure 2.1. Chemical structures of compounds examined in this study. Major torsion angles of
the compounds are marked in 1.
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Table 2.1. Solution Crystallization Results for Compounds Synthesized for this Study Specifying
the Polymorphic form Obtained and the Solvent Used for Crystallization.

Compounds

Polymorphic forms

Polymorphic screening

CSD Refcode

 – acetonitrile;

TOKSAO, TOKSAO01,

 - synthesis

TOKSAO02,

could not be isolated

TOKSAO03

reported in CSD
1

 Anhydrous 

2

1 Anhydrous - I

I – methanol

CUNKOM

3

1 Anhydrous- I

I - ethanol

--*

4

1 Anhydrous- I

I - ethanol

XENHII

5

1 Anhydrous - I

I – methanol

MUYRAA

6

1 Anhydrous - I

I - ethanol

MUYRII

8

4 Anhydrous- I, II, III, IV

Monohydrate – synthesis

MOTNUF, MOTNUF01,

1 Monohydrate

I – hexane: ethyl acetate

MOTNUF02, MOTNUF03

*new form identified in this study
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Figure 2.2. DSC reheating curves of compounds which were converted into glassy state on
cooling in DSC pans are shown in Panels A and C. Panel B shows the reheating DSC curves of
glassy solids prepared by melt quenching with liquid nitrogen. Panel D is the cooling curves of
compounds, that show rapid crystallization on cooling in DSC. (a.u. stands for arbitrary unit
because the thermograms were moved along the y-axis)
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Table 2.2. Thermal Properties of 12 Compounds Examined in this Study. The Crystallization
Outcomes on Melt Quenching in DSC Pan and with Liquid Nitrogen are also Specified.
(G=glassy state, C=crystalline state)

Compound

Molecular

Melting

Tg

Heat of fusion

Crystallization Outcome

Class

3

weight

point onset

Midpoint

(J/cm )

(g/mol)

(°𝐂)

(°𝐂)

1

214.22

151.3

44.9

141.3

G

G

II

2

228.25

164.7

50.5

154.3

G

G

II

3

242.28

135.6

38.4

95.2

G

G

III

4

256.31

168.3

49.9

110.2

G

G

III

5

232.21

156.2

38.6*

151.5

C

G

IB

6

232.21

193.5

51.9

183.3

G

G

II

7

262.69

239.4

50.7*

181.1

C

G

IB

8

228.25

129.5

27.2

140.2

G

G

III

9
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Figure 2.3. Semi-log plots of viscosities of compounds as a function of degree of supercooling.
Panel A – Class I compounds, Panel B – Class II compounds and Panel C – Class III compounds.
Panel D shows the average viscosities for the three Classes of compounds.

70

Table 2.3. Parameters Correlated to Glass Forming Ability of the Compounds Examined in the
Study.
Compound

Density
3

(g/cm )

Trg (Reduced

Free energy

Entropy of

glass

difference,

fusion, ∆𝑺fus X

transition

∆𝑮𝒗 (J/cm )

10-2 (Jcm-3 K-1)

3

Melt Viscosity
𝜼𝒎𝒆𝒍𝒕 X 10-2
(Pa. s)

temp)
1

1.416

0.74

-29.5

33.2

14.6

2

1.411

0.73

-33.5

35.2

21.7

3

1.259

0.76

-18.6

23.3

50.6

4

1.231

0.73

-24.1

24.9

22.7

5

1.496

0.72

-32.1

35.2

9.5

6

1.456

0.69

-42.3

39.2

--

7

1.410

0.63

-44.1

35.3

--

8

1.324

0.74

-26.9

34.8

--

9

1.324

0.68

-44.9

43.0

4.3

10

1.470

0.69

-45.7

35.9

--

11

1.35

0.70

-28.3

37.4

3.1

12

1.397

0.69

-45.4

39.4

6.2

--: data not acquired
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Figure 2.4. Average thermal and thermodynamic data of 12 compounds studied in this report
categorized according to the three classes of crystallization behavior. The statistical significance
was tested by Student’s t-test and * denotes p < 0.05.

72

Figure 2.5. Relationship of entropy of fusion (∆𝑆fus) with melt viscosity (A) and reduced glass
transition temperature (B) of model compounds from this study along with other
pharmaceutically relevant molecules taken from literature.87e The dashed lines are drawn to
provide visual aid in seeing the trend.
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Figure 2.6. Frequency histogram of ∆𝑆fus values for the entire data set of 60 compounds and three
classes of compounds.
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Figure 2.7. Relationship of entropy of fusion (∆𝑆 fus) with molecular weight (MW) of model
compounds from this study along with other pharmaceutically relevant molecules taken from
literature.87a, 87e

75

Figure 2.8. Pie graph demonstrates the percentage of compounds in Class IA (blue), Class IB
(red), Class II (green) and Class III (purple) with the hydrogen-bonded synthons (acid-acid; acidpyridine) found in the crystal structure.
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CHAPTER 3.

IMPACT OF SUPRAMOLECULAR AGGREGATION ON

THE CRYSTALLIZATION KINETICS OF ORGANIC COMPOUNDS
FROM THE SUPERCOOLED LIQUID STATE

3.1

Abstract

Despite numerous challenges in their theoretical description and practical implementation,
amorphous drugs are of growing importance to the pharmaceutical industry. One such challenge
is to gain molecular level understanding of the propensity of a molecule to form and remain as a
glassy solid. In this study, a series of structurally similar diarylamine compounds were examined
to elucidate the role of supramolecular aggregation on crystallization kinetics from supercooled
liquid state. The structural similarity of the compounds makes it easier to isolate the molecular
features that affect crystallization kinetics and glass forming ability of these compounds. To
examine the role of hydrogen-bonded aggregation and motifs on crystallization kinetics, a
combination of thermal and spectroscopic techniques was employed. Using variable temperature
FT-IR, Raman and solid-state NMR spectroscopies, the presence of hydrogen bonding in the
melt and glassy state was examined and correlated with observed phase transition behaviors.
Spectroscopic results revealed that the formation of hydrogen-bonded aggregates involving
carboxylic acid and pyridine nitrogen (acid-pyridine aggregates) between neighboring molecules
in the melt state impedes crystallization, while the presence of carboxylic acid dimers (acid-acid
dimers) in the melt favors crystallization. This study suggests that glass formation of small
molecules is influenced by the type of intermolecular interactions present in the melt state and
the kinetics associated with the molecules to assemble into a crystalline lattice. For the
compounds that form acid-pyridine aggregates, the formation of energy degenerate chains,
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produced due to conformational flexibility of the molecules, presents a kinetic barrier to
crystallization. The poor crystallization tendency of these aggregates stems from the highly
directional hydrogen-bonding interactions needed to form the acid-pyridine chains. Conversely,
for the compounds that form acid-acid dimers, the non-directional van der Waals forces needed
to construct a nucleus promote rapid assembly and crystallization.

3.2

Keywords

Glass-forming ability, crystallization, nucleation, amorphous, spectroscopy, molecular
interactions

3.3

Introduction

Amorphous formulations of drug molecules are of growing importance to the pharmaceutical
industry.11e, 15, 118 The low aqueous solubility and consequent poor bioavailability associated with
the crystalline state of many of newly developed drug candidates has propelled amorphous
formulations into greater relevance.9,

119

However, this high-energy state possesses excess

thermodynamic quantities including free energy, enthalpy and volume, which gradually drift
towards equilibrium values leading to either nucleation and subsequent crystallization or, in
other cases, structural relaxation (annealing) to a lower energy glassy state.11b,

37, 120

Understanding and predicting the stability of amorphous solids remains one of the key questions
for successful application of this solid state in formulation design.
Crystallization kinetics of organic drug molecules from supercooled melts has attracted
considerable research attention.71,

86c, 86e, 87a, 101, 121

The propensity of a material to vitrify is

referred to its glass forming ability (GFA).69, 112 Recent work of seeking molecular understanding
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of glass formation has highlighted some of the key molecular descriptors impacting the
vitrification of organic molecules. Properties such as molecular branching, a high number of
rotatable bonds, and distribution of electronegative atoms in molecules were positively
associated with glass formation, while other properties such as low molecular weight and high
number of benzene rings were found to promote crystallization.86c, 86e, 87a Because crystallization
involves molecular assembly through intermolecular interactions, the role of hydrogen bonding
on glass formation from melts has been studied using spectroscopic and computational
methods.80 For 2-biphenylmethanol, the formation of hydrogen-bonded tetramers during the
vitrification process has been reported and correlated with glass formation.81 A group of
structurally similar triazine compounds was examined and it was inferred that strong
intermolecular interactions such as hydrogen bonding could promote amorphization by forming
aggregates that pack poorly.82c, 122 Combining experimental studies with computation, one study
speculated that the presence of two distinct types of hydrogen-bonded motifs, which pack poorly,
was responsible for the good glass forming ability of salsalate.80c Conformational influence on
crystallization kinetics was studied for various systems including sugar alcohols.83a, 123 It was
found that sorbitol and iditol retain their glassy state upon cooling from the melt, while the
structurally related mannitol and dulcitol crystallize under similar conditions.123-124 It was thus
suggested that hindered crystallization of sorbitol or iditol results from the presence of distinct
conformers in the melt and the solid state.83a, 124b Similarly, it was suggested that the existence of
multiple molecular conformers of 2-methyl-1,3-propanediol prevents crystallization, while 1,3propanediol, structurally similar but lacking the methyl group, crystallizes readily.125
It is apparent that certain molecular features play an important role in glass formation.
However, understanding remains limited with respect to the role that these molecular features
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play in the formation of supramolecular assemblies during the initial stage of nucleation and
subsequent crystallization or amorphization. In this study, we compare the vitrification potential
of a series of structurally similar diarylamine compounds by analyzing molecular assemblies in
the melt, glassy and crystalline state. The diarylamine scaffold was systematically modified to
understand key molecular features on crystallization kinetics and glass-forming ability. The set
of compounds is divided into two broad categories based on their chemistry (Figure 3.1). Type 1
compounds (1-6) have both carboxylic acid and pyridine functional groups and can form both
acid-acid and acid-pyridine hydrogen-bonded motifs. In addition, they possess an intramolecular
hydrogen bond between the bridging amino group and the carboxylic acid in the crystal
structures (except compound 6). Type 2 compounds (7-9) lack the pyridine N and thus cannot
form acid-pyridine hydrogen bonding; the intramolecular hydrogen bond still exits in the crystal
structures.

3.4

Materials

Based on previously established methods, compounds 1, 2, 3, 4, and 6 were synthesized and
purified in our laboratory and the chemical structures and purity were verified using solution
NMR spectroscopy.100 Compounds 5, 7, 8 and 9 were purchased from TCI America (Portland,
OR) and used as provided (purity>98%). Solvents (acetonitrile, methanol, dichloromethane,
hexane, and ethyl acetate; ACS grade) were purchased from Macron (Center Valley, PA) and
ethanol (200 proof; USP grade) was obtained from Decon Labs (King of Prussia, PA).
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3.5

Methods

3.5.1 Powder X-ray diffraction
To verify the polymorphic forms of the compounds, a Rigaku Smartlab diffractometer (The
Woodlands, TX) with Cu Kα radiation (40kV, 40mA) was used to collect diffraction patterns
between 4.0° and 40.0° 2θ in the Bragg-Brentano configuration. A step size of 0.02° with a scan
rate of 4°/min was used for data collection at room temperature.
3.5.2 Differential scanning calorimetry
A Q20 differential scanning calorimeter (DSC) (TA instruments, New Castle, DE) equipped
with a liquid nitrogen cooling system (LNCS) was utilized for characterizing phase transition
behaviors of the compounds. Temperature and heat flow were calibrated by measuring the onset
temperature and enthalpy response of an indium standard. Tzero® hermetic aluminum pans and
lids were used in the experiments with a constant purge of helium gas at 25 mL/min. Samples
were hermetically sealed and heated at 10 °C/min to approximately 3-5 °C above the melting
offset. The samples were then cooled at the rate of 20 °C/min to −40 °C, and then reheated again
above the melting temperature at 10 °C/min.
3.5.3 Variable-temperature FTIR spectroscopy
A Bruker Vertex 70 FTIR spectrometer (KBr beam splitter, DTGS detector and 6 mm
aperture) fitted with a Golden-Gate diamond attenuated total reflectance (ATR) temperaturecontrolled accessory (Specac, Fort Washington, PA) was used to collect spectra at various
temperatures. A total of 64 scans at a resolution of 4 cm−1 were obtained. Because the IR
transmission of diamond shows temperature dependence, background spectra were also collected
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at each sampling temperature. OPUS (Bruker Optic, Version 7.2) was used to process the
collected spectra.
3.5.4 Raman spectroscopy
A Bruker Senterra Raman microscope equipped with a 785 nm laser and 20× objective was
used to collect sample spectra at a spectral resolution of 4 cm−1. A total of 20 co-additions with
an integration time of 5 sec were used for each measurement. OPUS (Bruker Optic, Version 7.2)
was used to process the Raman spectra.
3.5.5 Preparation of amorphous samples
Amorphous (glassy) samples were prepared by melt quenching. A known quantity of a
crystalline sample was heated a few degrees above its melting point, and the melt was then
immediately immersed in liquid nitrogen (−196 °C). Vitrification of the sample was verified
using XRPD and DSC. The amorphous samples for solid-state NMR experiments were prepared
immediately before data collection. However, if storage was required, the samples were stored in
a refregirator at approximately 4 °C.
3.5.6

13

C NMR spectroscopy

The spectra of crystalline/amorphous compounds 1 and 2 were obtained by using an Agilent
DD2-400 MHz (1H = 399.82MHz;

13

C = 100.55 MHz) SSNMR spectrometer. 4 mm PENCIL

type zirconia rotors were used for sample preparation and data was collected at ambient
temperature. Cross-polarization/magic angle spinning (CP/MAS) and total sideband suppression
(TOSS) were used to obtain the 13C SSNMR spectra. Additional operating conditions included a
spinning speed of 12 kHz, acquisition time of 30 ms, phase-modulated (SPINAL-64) high-power
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proton decoupling during acquisition, and an 1H pulse width of 2.9 s (90°). A CP contact time
of 5 or 2 ms was used for crystalline or amorphous samples, respectively.
The spectra of compounds 3, 4, 5, 7 and 8 were collected using a Chemagnetic CMX 400 MHz
(1H = 400.02MHz;

13

C = 100.59 MHz) spectrometer. 5mm zirconia rotor were used for sample

preparation and data collection was done at room temperature.

13

C spectra were obtained with

cross-polarization/magic angle spinning (CP/MAS) and total sideband suppression (TOSS).
Operating conditions included a CP contact time of 3.5 ms for all samples, spinning speed of 6
kHz, acquisition time of 16 ms, TPPM high power proton decoupling, and an 1H pulse width of 5
s (90°).
The pulse delay time was different for each compound, with amorphous samples requiring
much less recycle delay than crystalline samples. The

13

C SSNMR spectra were externally

referenced to the carbonyl carbon resonance of glycine at 176.5 ppm. The free induction decays
were processed using Agilent VnmrJ 3.2A or Spinsight Version 4.3.2 software and an
exponential line broadening factor of 20 Hz was used to improve the signal-to-noise ratio.
3.5.7 Ab initio calculations and molecular modeling
The hydrogen-bonding energy of the molecules was calculated by quantum mechanics.126
Experimentally determined crystal structures were optimized at the B3LYP/6-21G(d,p) level
with the lattice parameters fixed by Crystal09.127 From the optimized crystal structures,
hydrogen-bonded pairs were extracted and subjected to single-point energy calculations at
B3LYP/6-311++G(d,p) by Gaussian09.126 The hydrogen-bonding energy was calculated by
subtracting twice the monomer energy from the energy of the dimer (acid-acid or acid-pyridine)
with the basis set superposition error (BSSE) corrected by the counterpoise method.128
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For molecules that do not form crystal structures with the acid-acid or acid-pyridine synthon,
hydrogen-bonding strength of the synthon was calculated by taking the energy minimum from a
plot of hydrogen-bonding energy of the motif versus intermolecular O/O distance of the
neighboring acid-acid group or the O/N distance of the hydrogen-bonded pair. The pair of
molecules for each data point were partially optimized with the O/O or O/N distance fixed.
Empirically augmented density functional theory (DFT) method was used for lattice energies
calculation of the α and δ polymorphs of 1.129 The crystal structures were optimized with a basis
set of B3LYP/6-21G(d,p). Diffuse orbitals were not included due to potential instability
introduced to Bloch functions. The single-point energy of optimized crystal structures was then
calculated (the van der Waals energy component was included through empirical equations) and
the lattice energy was computed as the difference between the total corrected energy of a crystal
system and the lowest energy of a fully optimized single molecule in vacuum.
Hirshfeld surfaces for the acid-acid and acid-pyridne dimers of 1 were generated using Crystal
Explorer (Version 3.1, Revision 1448).130 The optimized crystal structures of 1 were used for the
calculation.

3.6

Results

3.6.1 Polymorph crystallization and crystal structure analysis
To understand the phase behavior, especially with regard to preference for crystallization or
amorphization, crystal structures of all compounds were analyzed, including molecular packing
and the preferred hydrogen-bonding motif (Figure 3.2). Polymorphic forms obtained after
crystallization were verified using powder X-ray diffraction.
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Compound 1 is known to have four polymorphs (α, β, γ, δ).100a In the α polymorph (Figure
3.2a), the molecules adopt a –COOH∙∙∙–COOH [HOC=O∙∙∙HOCO] hydrogen-bonded dimer
synthon while in the δ polymorph, –COOH∙∙∙pyridine N hydrogen-bonded catemers (Figure 3.2b)
are observed. A total of nine different conformers, mainly differing in torsion angle , are found
in all four crystal structures with the conformationally isomorphic δ polymorph possessing two
crystallographic independent molecules in its asymmetric unit.100a Compound 2 (Figure 3.1c) has
one reported polymorph which adopts the acid-acid homosynthon.100c In order to discover
possible polymorphs with acid-pyridine chains, polymorph screening was attempted. Despite the
effort, no new form was obtained. Compound 3 displays one-dimensional chains of the acidpyridine heterosynthon in the reported crystal structure (Figure 3.2d).100c The crystal contains 8
molecules in the unit cell with Z’=2.100c Polymorphic screening in various solvents yielded only
the reported solid form, and no acid-acid homosynthon containing crystal structure was found.
Molecules in compound 4 pack as acid-acid dimers with Z’=1 (Figure 3.2e).100d A new
polymorphic form of this compound was obtained during crystallization from the amorphous
sample and will be discussed elsewhere. Compound 5 (clonixin) has four reported polymorphs (I,
II, III and IV).131 While forms I, III and IV are neutral, polymorph II is zwitterionic. Form I is the
most stable form at room temperature and is enantiotropically related to forms III and IV.103 In
polymorph I, the molecules adopt –COOH∙∙∙pyridine N hydrogen-bonded catemers (Figure 3.2f),
while in the polymorphs III and IV–COOH∙∙∙–COOH hydrogen-bonded dimers are observed
(Figures 3.2g and 3.2h respectively). Compound 6 has four reported anhydrous polymorphs (I, II,
III, IV) and one monohydrate form.100b All forms possess acid-pyridine hydrogen bonded
catemers. Form I, the most stable form, was used for the subsequent experiments.100b Compound
7 (fenamic acid) lacks the pyridyl N and adopts the acid-acid dimer synthon (Figure 3.2i). There

85
are two different conformers (Z’=2) in the asymmetric unit of the only crystal structure that is
reported in the literature.104 Compound 8 (mefenamic acid) has three reported polymorphs (I, II
and III). At room temperature, Form I is the most stable form and was provided by the supplier.17
These conformational polymorphic forms exhibit –COOH∙∙∙–COOH hydrogen-bonded dimers in
the crystal structures. Compound 9 (tolfenamic acid) has five reported crystal structures but only
two polymorphs are commonly encountered.132 Form I (colorless) and Form II (yellow) II differ
mainly in the torsion angle τ1 (−74.9° and −142.6° of forms I and II, respectively) with similar –
COOH∙∙∙–COOH hydrogen-bonded dimers in the two forms (Figure 3.2j). Form I is reported as
the most stable polymorphic form and was provided by the supplier.133
The crystal structure analyses demonstrate that these molecules can adopt either acid-acid or
acid-pyridine synthon in the crystal structure suggesting that, if the molecules have to crystallize
from the supercooled liquid upon cooling and form a glassy solid, they have to either form –
COOH∙∙∙pyridine N catemers or –COOH∙∙∙–COOH dimers during the early stages of
crystallization.
3.6.2 DSC evaluation of crystallization from supercooled liquid state
Phase transition kinetics of the compounds along with thermal properties (melting points,
enthalpies of melting, and glass transition temperatures) were determined by DSC (Table 3.1).
On cooling from the melt state, compounds 1, 2, 3 and 6 avoided crystallization and formed
glassy solids. On the other hand, compounds 4, 5, 7, 8 and 9 showed exothermic crystallization
peaks in the supercooled melt region. The inability of compound 8 (mefenamic acid) and
compound 9 (tolfenamic acid) to form glasses was reported previously (using melt quenching,
spray drying and/or cryomilling).33a,

87a

On reheating, compounds 1 and 2 recrystallized and

subsequently demonstrated melting peaks. For compound 2, the melting point of the re-
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crystallized solid was identical to that of the starting material; however, for compound 1, the
recrystallized solid melted at the same temperature as the β polymorph.
Phase transitions, such as crystallization, can be affected by the cooling rate employed during
experiment, with rapid cooling rates often precluding re-crystallization events.87a, 108b, 134 Our
DSC experiments utilized a moderate cooling rate of 20 °C/min. To examine the effect of higher
cooling rates, the melts were quenched with liquid nitrogen. Under these conditions, all
compounds demonstrated the same phase behavior except compounds 4 and 5, which turned into
glassy solid with Tg’s of 38.6 °C and 51.7 °C respectively.
Based on their crystallization tendency, our compounds were divided into three groups based
on the scheme reported by Baird et al.87a Class I compounds are rapid crystallizers (IA crystallize even under rapid cooling with liquid nitrogen or IB - vitrify upon cooling with liquid
nitrogen). Class II compounds are good glass formers with poor stability on re-heating, and Class
III compounds are good glass formers that exhibit stability on re-heating. From Table 3.1, it can
be seen that compounds containing the pyridine N generally fall into Class II/III/IB and hence
are glass formers. In contrast, compounds lacking this structural feature crystallize rapidly. This
correlation is best exemplified by comparing compound 1 with 7 and compound 5 with 9, which
differ only in the pyridine N, yet display distinct phase behaviors.
3.6.3 Spectroscopic investigation of molecular interactions
To understand the distinct phase behaviors of these structurally similar compounds,
intermolecular interactions in the amorphous state were examined and compared to those found
in the crystals.

13

C SSNMR spectroscopy is a powerful technique because of the sensitivity of

chemical shift to the electronic environment of a carbon atom in a solid sample. The resonant
frequency of the carboxylic acid carbonyl carbon (typically observed between 165-175 ppm) is
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extremely sensitive to the hydrogen-bonding motif.135 As seen from values listed in Table 3.2,
13

C SSNMR chemical shifts of crystalline solids containing the acid-acid synthon are shifted to

higher frequency by 3-5 ppm compared to the acid-pyridine synthon. For the carboxylic
functional group involved in a relatively weak hydrogen bond, the carbonyl carbon tends to have
slightly greater electron density (shielded) surrounding it and results in a higher peak frequency.
13

C SSNMR spectra of crystalline (α, δ polymorph) and amorphous samples of compound 1

are shown in Figure 3.3A. The spectrum of the δ polymorph (Figure 3.2A(ii)) displays peak
splitting for most carbon atoms. This is characteristic of two conformationally distinct molecules
in the asymmetric unit (Z’=2). Similar peak splitting is seen for compound 3 (Figure 3.3D(i)) and
compound 7 (Figure 3.3F) where Z’=2. Of significance is the resonance frequency of the
carboxylic acid carbon because of its involvement in formation of hydrogen bonding (Table 2).
For the α polymorph (Figure 3.3A(i)), δ polymorph (Figure 3.3A(ii)) and amorphous form
(Figure 3.3A(iii)), the chemical shifts are observed at 174.4, 169.1, and 169.9 ppm, respectively.
Similar values in the melt quenched amorphous sample and the δ form suggest that the electronic
environment of carbonyl carbon is similar, corresponding to the carboxylic acid-pyridine
intermolecular interaction. Analogous results were observed for other glass forming compounds.
For compound 5 (shown in Figure 3.3B), the chemical shift of the carbonyl carbon for acidpyridine synthon containing Form I (Figure 3.3B(i)) and amorphous phase (Figure 3.3B(iv))
occur at 169.1 and 169.5 ppm, respectively. For Form III (Figure 2B(ii)) and IV (Figure
3.3B(iii)), the chemical shifts are 174.9 and 172.7 ppm, respectively. For compound 3, a peak
position of 169.0-170.4 ppm (Z’=2) was detected for Form I (containing the acid-pyridine
synthon) and 169.6 ppm for amorphous samples. In the case of compound 2, the glassy sample
was prepared by melt quenching and the carbonyl carbon peak appeared at 169.6 ppm, compared
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with 174.0 ppm for the crystalline sample (acid-acid synthon). A polymorph containing the acidpyridine synthon could not be obtained by polymorph screening for this compound. Finally,
while compound 4 could be converted to the glassy phase by melt quenching with liquid nitrogen,
it displayed rapid crystallization. For Form I (Figure 3.3E(i)), the carbonyl carbon peak appears
at 174.0 ppm, while for the partially crystallized sample (Figure 3.3E(iii)), two distinct peaks are
seen at 174.0 and 170.1 ppm. The new polymorph (Form II) shows the carbonyl carbon peak at
174.3 ppm. For compounds 7, 8 and 9, NMR analysis was not possible because of rapid
crystallization and inability to prepare amorphous samples by melt quenching. These results
indicate that the compounds bearing the acid-pyridine interaction in the melt could form the
amorphous state.
To further investigate the intermolecular interactions, mainly hydrogen bonding, in the
amorphous state, variable temperature FTIR and Raman spectra were collected. The carbonyl
and pyridine functional groups in our compounds can be either involved in –COOH∙∙∙pyridine N
or –COOH∙∙∙–COOH interactions. The carbonyl stretching vibration thus provides a useful way
of identifying molecular speciation by comparing the amorphous/melt spectra with those of the
crystalline samples. Examining the melt state is especially critical for compounds 7, 8 and 9
since these could not be prepared as amorphous samples for SSNMR analysis.
Carbonyl stretching for conjugated carboxylic acids is usually detected in the region of 16501800 cm−1, with strong IR bands, while Raman bands are often of weak or medium intensity.136
FTIR spectra of various states of compound 1 are shown in Figure 3.4, including α polymorph, δ
polymorph, melt, and amorphous solid. For the α polymorph (Figure 3.4Ai), the peak at 1648
cm−1 with a shoulder at 1660 cm−1 denotes the overlap of the in-plane deformation of N–H peak
with the asymmetric carbonyl symmetric stretching vibration, while for the δ polymorph (Figure
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3.4Aii), these vibrational bands are observed overlapping with peaks roughly at 1643 and 1663
cm−1. The in-plane deformation of N–H in the region 1650–1600 cm−1 that overlaps with the
C=O stretching band has been observed for similar compounds.45, 137 Furthermore, the lower
wavenumbers associated with these bands can be explained by the presence of intramolecular
hydrogen bonding between the bridging N-H and C=O. This is verified by comparing the FT-IR
spectrum of compound 6 (Figure 3.4B) that shows the carbonyl stretching vibration at 1712 cm−1
because the N-CH3 group prevents formation of the intramolecular hydrogen bonding. In the
melt state of compound 1, the two overlapping bands appear as distinct peaks at 1643 and 1684
cm−1. The peak at 1643 cm−1 is again assigned to the in-plane deformation of N–H, while the
other peak at 1684 cm−1 is assigned to carbonyl stretching vibration. This peak position shifts to
1679 cm−1 in the amorphous solid sample. The vibrational band positions for compounds 2, 3
and 4 are reported in Table 3.3.
Unlike compounds 1-6, compound 7 cannot form acid-pyridine but only forms acid-acid
hydrogen bonding because it lacks the pyridine nitrogen. Figure 3.4C shows the carbonyl stretch
region of the sole reported crystalline sample with the peak position at 1652 cm −1 measured at
room temperature. As the solid melts, the peak shifts from 1652 to 1656 cm−1. This suggests that
even on melting, acid-acid hydrogen-bonded dimers are retained in the melt although the
interaction may be weakened. Similar results were obtained for compounds 8 (Figure 3.4D) and
9 (Table 3.3).
The Raman spectra (Figure 3.5) were examined for the corresponding symmetric C=O stretch
in the region of 1650-1690 cm−1. While the FTIR spectrum of compound 1 shows the
asymmetric stretch, the symmetric stretching is inactive for the α polymorph in Raman spectrum
(Figure 3.5a). However, the δ polymorph shows a weak symmetric stretch (in addition to the
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asymmetric stretch in IR spectra) band at 1660 cm−1 (Figure 3.5b). The Raman spectrum of the
amorphous sample shows a weak band at 1682 cm−1 (Figure 3.5b). The amorphous state shows
both IR and Raman stretch bands similar to those of the δ polymorph. Combined with the
SSNMR spectroscopic data, it was concluded that the melt and amorphous states of compound 1
contain acid-pyridine hydrogen bonded aggregates.
Similar results were observed for compound 5 (clonixin) with the polymorphic Form I
showing both IR and Raman peaks at 1677 cm−1. For Forms III and IV, only asymmetric
stretching vibrations show IR active bands with no corresponding peaks in Raman spectra. For
the amorphous phase, the IR and Raman peaks are observed at 1679 and 1680 cm−1, respectively.
These results point to the absence of acid-acid dimers in the amorphous state, and combined with
SSNMR data, suggest the existence of acid-pyridine hydrogen bonded aggregates. Clearly, for
those compounds that can form both acid-acid and acid-pyridine hydrogen-bonding motifs,
choosing to form the acid-pyridine motif in the melt/amorphous state is correlated with their
glass forming abilities.

3.7

Discussion

Understanding glass-forming ability is of extreme importance in developing amorphous
formulations for poorly water-soluble drugs. A fundamental understanding of molecular factors
that influence the vitrification potential is critical. Studying the crystallization kinetics of a
molecule from its liquid (melted) state upon cooling could shed light on its glass-forming ability.
Crystallization kinetics is dictated by the energy barrier for the molecules in the melt/amorphous
state to build up long-range, orderly packed supramolecular structures. The influence of
molecular structure on crystallization kinetics is highlighted by the differing phase transition
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behaviors of structurally similar compounds in this study, which, by and large, cannot be
predicted a priori.122a, 138 In this work, the effect of molecular structure on crystallization from
supercooled melts was explored by studying a series of structurally similar compounds.
The results from this study show that the formation of –COOH∙∙∙pyridine N interactions over –
COOH∙∙∙–COOH in the melt state leads to glass formation, as shown by compounds 1-6. The
experimental results also suggest that the presence of –COOH∙∙∙–COOH interactions in the melt
state leads to rapid crystallization on cooling. This was observed for compounds 7, 8 and 9,
where the hydrogen-bonded acid-acid dimers nucleate and crystallize readily. This is evident
from the spectroscopic data that probes the hydrogen bonding of the molecules in the melt,
crystalline and amorphous samples of the compounds. Variable temperature FTIR was utilized to
examine the hydrogen bonding state of compounds 7-9 in the melt state. Because these
compounds form centro-symmetric carboxylic acid dimes in their crystal structures, the change
in carbonyl stretching vibration was examined on melting. The small shift observed in this
vibration band (Table 3) indicates that these molecules preserve the carboxylic acid dimer
configuration, although this interaction is slightly weaker than that in the solid state. Furthermore,
the aromatic ring vibrations (Table 3.3) in the melt state also show slight deviation from that in
the crystalline state, indicating conformational changes of the molecules.

13

C SSNMR

spectroscopy proved to be a valuable technique in distinguishing specific hydrogen-bonding
interactions in the amorphous solid state. The acid-pyridine and acid-acid synthons demonstrate
a difference of 3-5 ppm in chemical shift of the carbonyl carbon. On average, for the acid-acid
synthon-containing crystal structures, the chemical shift of the carbonyl carbon is 174.5 ± 1.2
ppm. On the other hand, for the acid-pyridine crystal structures and amorphous samples, the
respective chemical shift values are 169.3 ± 0.3 and 169.7 ± 0.2 ppm.
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Comparing compounds 1 with 7 and 5 with 9, respectively, the role of intermolecular
interactions on crystallization kinetics is clearly illustrated. The lack of pyridine N in compounds
7-9 renders the molecules poor glass formers. The formation of acid-pyridine aggregates over
acid-acid dimers in the melt of compounds 1-3 was further examined by calculating the strength
of the hydrogen-bonding interactions (Table 3.4). It can be seen that the acid-pyridine hydrogen
bonding is stronger than that of carboxylic acid dimers of these compounds by approximately 20
kJ/mol. This likely leads to formation of locally preferred molecular pairs and even large
associations via the pyridine N∙∙∙acid hydrogen bonding. Nonetheless, these hydrogen-bonded
chain motifs may need to convert to the acid-acid pairs in forming a crystal (as observed during
re-crystallization of compounds 1, 2, 4 and 5 during the re-heating the amorphous sample in
DSC experiments (data not shown). This is because, collectively, a crystal with the acid-acid pair
may have a stronger lattice energy than a crystal with acid-pyridine motif of the same molecule.
For example, the α polymorph of compound 1 has stronger calculated lattice energy −113.91
kJ/mol) than the δ form (−98.04 kJ/mol). Other intermolecular interactions including π–π
stacking and van der Waals forces become more significant when more molecules start to encase
an acid-acid pair. Clearly, disrupting the hydrogen-bonded molecular species in the liquid state
in order to form a new motif in the crystal results in kinetic obstacles. It is also possible that the
kinetic process is relatively easy when the hydrogen-bonded pairs remain unchallenged from the
melt state to the crystalline state. Apparently, compounds 7-9 bear this trait.
When acid-pyridine molecular aggregates are present in the supercooled liquid, crystallization
is impeded, thereby promoting vitrification. Frustration in liquid structure is considered an
important factor in the inhibition of crystallization, in which a considerable difference in the
locally favored structure in the melt state and crystalline state is considered to play a crucial
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role.113a While liquid/melt lacks long-range order, it can possess short-range ordering due to
specific interactions between molecules (or atoms). According to Tanaka’s two-order-parameter
description of liquids139, in any liquid there exist two local orderings or structures competing
with each other, normal liquid where molecules are randomly packed and locally favored
structures where molecules may form some ordering via intermolecular interactions. These
locally favored structures are believed to have a symmetry inconsistent with that of the
corresponding crystal structure and present kinetic barriers for crystallization.139 For compounds
1-6, it is possible that acid-pyridine aggregates form multiple hydrogen-bonded catemers (locally
favored structures), which are energy similar and thereby having little driving force for
crystallization. Torsion angle 1 (Figure 3.1) of these molecules shows large conformational
diversity but these large variations differ by only a few kJ/mol. If such a compound prefers the
acid-acid motif in the crystal structure, realignment of molecular speciation during the nucleation
process could present a formidable barrier for the self-assembly of crystallizing species.
Conversely, if the locally favored dimer structures are also energy-favored in the crystal,
crystallization could readily occur.
Furthermore, low molecular mobility is associated with acid-pyridine hydrogen-bonded chains,
which can contribute to the glass-forming ability. According to Classical Nucleation Theory
(CNT), nucleation rate (J) can be described by an Arrhenius equation in which, the preexponential factor, 𝐴, is determined by a term describing the frequency of attachment (f*) of
building units to the growing cluster (Equations 1 and 2).53, 57
𝐵

J = A exp (- 𝑘 𝑇)
𝐵

A = z f* C

Equation 3.1
Equation 3.2
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where B is free-energy barrier for nucleus formation, kB is the Boltzmann factor, T is the
temperature, z is Zeldovich factor, and C is nucleus concentration. f* is determined by the
diffusion coefficient of growth units, which is influenced by energy barriers originating from
conformational change associated with incorporation of molecules in a nucleus.53, 57 The low
addition frequency of acid-pyridine hydrogen bonded aggregates could be explained by the
highly directional hydrogen bonding interaction needed to form catemers (Figure 3.6) as well as
the conformational diversity in the melt/amorphous state. The changes in aromatic ring
vibrations between crystalline and amorphous states of compounds 1-6 shown in Table 3 indicate
conformational diversity in the amorphous state (with respect to the crystalline state). Apparently,
these locally formed chain structures lead to increase in the free-energy barrier for nucleation (B
in Equation 1).96 In contrast, the non-directional van der Waals forces needed to construct a
nucleus from carboxylic acid dimers promotes rapid assembly and crystallization (Figure 3.6).
Such difference in molecular speciation in the melt state is believed to be the determining factor
for the crystallization kinetics observed in this study

3.8

Conclusions

This study examined the role of intermolecular interactions on the crystallization kinetics and
glass forming ability of a series of structurally similar organic molecules. It was discovered that
the acid-pyridine hydrogen-bonded association of molecules in the melt state presents a
significant kinetic barrier to crystallization. On the other hand, the presence of carboxylic acid
hydrogen-bonded dimers in the melt state resulted in rapid crystallization. The impeded
crystallization kinetics of energy-similar acid-pyridine chains is a result of poor efficiency in
attachment of growth units and realignment of molecular conformations. This work highlights
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the role of supramolecular aggregates in the melt state and their ability to either promote or
hinder glass formation.

3.9

Acknowledgements

"Reprinted (adapted) with permission from Mol. Pharmaceutics, 2017, 14 (6), pp 2126–2137,
DOI: 10.1021/acs.molpharmaceut.7b00245, Publication Date (Web): May 9, 2017.Copyright
2017 American Chemical Society."

96

Figure 3.1. Chemical structures of compounds examined in this study. Major torsional angles are
highlighted in 1.
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Figure 3.2. View of major synthons seen in the crystal structures of select compounds: 1 (α
polymorph) – (a), Compound 1 (δ polymorph) – (b), Compound 2 – (c), Compound 3 – (d),
Compound 4 – (e), Compound 5 (Form I) – (f), 5 (Form III) – (g), 5 (Form IV) – (h), Compound
7 – (i), Compound 9 (Form 1) – (j). Synthons for compounds 6 and 8 are not shown.
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Table 3.1. Physical and Thermal Properties of the Compounds Examined in the Study.

Compounds

MW

Tm onset

(g/mol)

(°C)

Enthalpy

Tg

of melting

onset

(J/g)

(°C)

98.4

46.85

α: 153.26
1

214.22

β: 145.00
δ: 136.34

Synthon in crystal
structures

acid-acid
acid-pyridine

2

228.25

163.69

115.0

43.32

acid-acid

3

256.30

168.26

90.2

45.59

acid-pyridine

4

232.21

153.27

94.4

38.64*

acid-acid

5

262.69

239.40

128.5

51.70*

6

228.25

130.88

116.0

26.42

acid-pyridine

7

213.23

185.51

142.2

---

acid-acid

8

241.29

231.54

140.0

---

acid-acid

9

261.71

211.98

137.1

---

acid-acid

* Measured after melt quenching with liquid nitrogen

acid-acid

Class

II

II

III

IB

IB

acid-pyridine
III

IA

IA

IA
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Figure 3.3. 13C Solid-state NMR spectra: Panel A – Compound 1 (α polymorph - i, δ polymorph
– ii, and amorphous - iii); Panel B – Compound 5 (Form I – i, Form III – ii, Form IV – iii,
amorphous - iv); Panel C – Compound 2 (Form I – i, amorphous - ii); Panel D – Compound 3
(Form I – i, amorphous - ii); Panel E – Compound 4 (Form I – i, Form II – ii, amorphous - iii);
Panel F (7 – i and 8 – ii).

100

Table 3.2. The Chemical Shift Value (in ppm) of the Carboxylic Acid Carbon as Observed using
13

C Solid State NMR Spectroscopy.
Compound

Solid state

Hydrogen bonding synthon in
crystal structure

Carboxylic acid C=O
chemical shift value (ppm)

1

α polymorph

acid-acid

174.4

δ polymorph

acid-pyridine

169.1

amorphous

--

169.9

Form I

acid-acid

174.0

amorphous

--

169.6

Form I

acid-pyridine

169.0-170.4

amorphous

--

169.6

Form I

acid-acid

174.0

Form II

acid-acid*

174.3

amorphous

--

170.1

Form I

acid-pyridine

169.1

Form III

acid-acid

174.9

Form IV

acid-acid

172.7

7

amorphous
Form I

-acid-acid

169.5
177.7-176.3

8

Form I

acid-acid

174.7

2

3

4

5

* Crystal structure not available.

101

Figure 3.4. Panel A: VT-FTIR spectra of compound 1: α polymorph (i), δ polymorph (ii), melt
(iii), and amorphous phase (iv); Panel B: Compound 6 in crystalline state (i), and melt state (ii)
and amorphous phase (iii); Panel C: Compound 7 in crystalline state (i), and melt state (ii); Panel
D: Compound 8 in crystalline state (i), and melt state (ii).
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Table 3.3. Variable Temperature FTIR Data of the Model Compounds in Crystalline, Melt and
Amorphous State Showing the Carbonyl and Aromatic Ring Vibrations.
Compound

Solid-state

1

α polymorph
δ polymorph
melt
amorphous
Form I

Carbonyl (C=O) vibration
(cm-1)
1660.0 (sh)
1663.0 (sh)
1684.0
1679.0
1668.4

melt
amorphous
Form I
melt
amorphous
Form I

1682.0
1678.0
1658.0
1684.0
1677.7
1675.0

melt

1681.0

amorphous

1680.0

Form I
Form III

1677.0
1663.5

Form IV

1675.4

amorphous
Form I
melt
amorphous
Form I
melt
Form I
melt
Form I
melt

1679.1
1712.0
1700.0
1669.0
1652.4
1656.1
1645.0
1647.0
1654.6
1656.0

2

3

4

5

6

7
8
9
sh = shoulder

Aromatic (C=C, C=N) ring
vibrations (cm-1)
1610.2, 1585.0, 1570.0
1595.0, 1580.0
1588.0, 1572.0
1592.0, 1574.0
1615.3, 1600.2, 1584.4,
1517.7
1611.0, 1580.0
1613.0, 1583.0, 1553.0
1597.7, 1581.2
1580 .0
1611.1, 1582.7, 1554.8
1622.0, 1603.0, 1591.0,
1574.0
1616.0, 1600.0, 1586.0,
1574.0
1618.0, 1602.0, 1589.0,
1554.6
1593.5, 1578.9
1608.2, 1596.4, 1579.9,
1566.1
1615.8, 1594.4, 1580.0,
1566.1
1609.8, 1580.1
1585.0, 1565.0
1579.8, 1559.0
1623.0, 1581.0, 1560.0
1587.6, 1573.2
1585.3, 1570.4
1620.0, 1600.0, 1587.0
1618.0, 1600.0
1620.7, 1597.2
1584.0
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Figure 3.5. Raman spectra of compound 1: α polymorph (a), δ polymorph (b), amorphous-state
(c).
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Figure 3.6. Hirshfeld surfaces of acid-pyridine and acid-acid dimer of 1. The red spots indicate
the contacts shorter than van der Waals distance, while blue indicates longer contacts.
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Table 3.4. Hydrogen Bonding Energies of Compounds 1-3.

Compound

∆E (–COOH∙∙∙–COOH)
(kJ/mol)

∆E (–COOH∙∙∙N–)
(kJ/mol)

1

−32.07

−49.64

2

−32.85

−53.15

3

−33.54

−50.70
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CHAPTER 4.

EXPLORING MOLECULAR SPECIATION AND

CRYSTALLIZATION MECHANISM OF AMORPHOUS 2PHENYLAMINO NICOTINIC ACID

4.1

Abstract

Molecular understanding of phase stability and transition of the amorphous state helps in
formulation and manufacturing of poorly-soluble drugs. Crystallization of a model compound, 2phenylamino nicotinic acid (2PNA), from the amorphous state was studied using solid-state
analytical methods. Our previous report suggests that 2PNA molecules mainly develop
intermolecular –COOH∙∙∙pyridine N (acid-pyridine) interactions in the amorphous state. In the
current study, the molecular speciation is explored with regard to the phase transition from the
amorphous to the crystalline state. Using spectroscopic techniques, the molecular interactions
and structural evolvement during the recrystallization from the glassy state were investigated.
The results unveiled that the structurally heterogeneous amorphous state contains acid-pyridine
aggregates – either as hydrogen-bonded neutral molecules or as zwitterions – as well as a
population of carboxylic acid dimers. Phase transition from the amorphous state results in crystal
structures composed of carboxylic acid dimer (acid-acid) synthon or acid-pyridine chains
depending on the crystallization conditions employed. The study underlines the structural
evolvement, as well as its impact on the metastability, of amorphous samples from local,
supramolecular assemblies to long-range intermolecular ordering through crystallization.
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4.2

Keywords

Crystallization, amorphous, variable temperature Raman spectroscopy, molecular dynamic
simulations, solid-state NMR spectroscopy, nucleation, phase transition

4.3

Introduction

Crystallization of amorphous drug formulations is detrimental to the product quality and
bioavailability. Molecular-level understanding of crystallization mechanism can help in rational
selection of polymeric excipients to hinder such events.10, 66 Examining the mechanistic steps
involved in crystallization of organic molecules under conditions of supersaturation or
supercooling is a challenging task both experimentally and theoretically.140 The phase transition
occurs over several orders of magnitude spatiotemporally, difficult to trace at the molecular level.
Still, attempts have been made to identify molecular aggregation and re-organization in the
amorphous state that are linked with the supramolecular packing found in resultant crystals.32, 141
For example, hydrogen-bonding interactions in amorphous indomethacin were examined using
vibrational spectroscopy,11g solid-state NMR spectroscopy,11h and molecular dynamic
simulations,142 with the crystallization outcome being monitored using microscopy.143 It was
found that a variety of molecular aggregates of indomethacin are present in the amorphous state,
including carboxylic acid cyclic dimers, carboxylic acid-amide interactions, carboxylic acid
catemers, and free molecules. The  polymorph which contains cyclic dimer motif crystallizes at
temperatures below the glass transition temperature (Tg), while the metastable  form, which
contains the trimer motif forms at temperatures above the Tg.142 Despite these efforts, attempts to
link molecular speciation to crystallization remain scarce. Here we report crystallization of 2-

108
phenylamino nicotinic acid (2PNA) from the amorphous state by examining supramolecular
aggregation and its influence on the crystallization outcome.
In our previous work to examine the molecular basis of glass formation, we have studied the
crystallization behavior of a series of diarylamine compounds that can either form acid-acid
hydrogen-bonded dimers or acid-pyridine hydrogen-bonded motif.144 We explored the
relationship between thermodynamics and kinetics on glass formation to highlight the
importance of entropy of fusion in regulating melt viscosity.144a Furthermore, by using
spectroscopic tools to examine the melt/supercooled liquid state, the impact of specific
hydrogen-bonded motifs on crystallization kinetics was examined.144b In particular, the presence
of acid-pyridine hydrogen-bonded associations was observed in the melt state, believed to
contribute a significant kinetic barrier to crystallization. On the other hand, the presence of
carboxylic acid hydrogen-bonded dimers in the melt state is thought to be responsible for rapid
crystallization. In line with our previous work, the purpose of our current study is to gain further
understanding of crystallization mechanism from the amorphous state of 2PNA (Figure 4.1). The
compound was shown to be a good glass forming compound.144 Structurally, the fascinating
feature of this molecule lies in the presence of carboxylic acid functional group along with the
pyridine ring, which enables the crystallization competition between crystal structures with either
the acid-acid or the acid-pyridine synthon.

4.4

Materials

2PNA was synthesized in our laboratory by a previous established method.100a Deuterated
dimethyl-sulfoxide (DMSO-d6) for solution NMR experiments was purchased from Cambridge
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Isotope Laboratories, Inc. (Tewksbury, MA). The organic solvents - methanol, toluene, acetone,
chloroform, acetonitrile - were obtained from Macron (Center Valley, PA) and ethanol (200
proof) was obtained from Decon Labs (King of Prussia, PA).

4.5

Methods

4.5.1 Sample Preparation
4.5.1.1

Polymorph crystallization

The  polymorph of 2PNA was obtained by slow cooling the reaction mixture and was further
purified by seeding a supersaturated solution in ethanol: water (80:20) mixture. The 
polymorph was obtained by re-crystallization from ethanol.
4.5.1.2

Preparation of amorphous samples

Crystalline sample was heated a few degrees above the melting point, and the melt was then
immediately immersed in liquid nitrogen to obtain the amorphous sample.
4.5.2 Solution-state Analysis
4.5.2.1 Solution NMR spectroscopy
A Bruker DRX 500MHz spectrometer equipped with a 5 mm BBFO (broadband) Z-gradient
probe was used to obtain the 13C and 1H spectra of 2PNA in DMSO-d6 at ambient temperature.
4.5.2.2 Solubility Studies
The solubility of 2PNA was measured in ethanol, toluene, acetone, acetonitrile, methanol and
chloroform at 25°C. The method involved placing an excess amount of solid in a 20 mL
borosilicate vial (in triplicate) and allowing the system to equilibrate with constant stirring. The
vial was placed in a jacketed beaker for atleast 72 hours at the desired temperature. A sample of
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the saturated solution was taken out using a syringe, filtered through a PTFE filter (0.45 μm pore
size), and diluted for UV analysis at 365 nm (Molecular Devices, Spectramax M2). X-ray
diffraction was used to examine the residual solid phase left after equilibration for 72 hours.
4.5.2.3 Thermal stability of 2PNA
An Agilent Technologies 1100 Series HPLC equipped with an injection system with 100 L
loop was used to identify any potential thermal degradation of 2PNA during melt quenching.
Detection was accomplished with a UV photo diode array detector at 280 nm. Integration and
system parameters were controlled by ChemStation for LC systems (Rev. B.04.03 16) software.
Chromatographic analyses were carried out at room temperature on a 4.6 × 150 mm 300 Extend
C18 ZORBAX column. The separation was achieved by isocratic elution with a flow rate of 1.0
mL/min. The mobile phase consisted of acetonitrile and water (55:45 V/V) adjusted to pH 2.5 by
acetic acid.

4.5.3 Solid-state Analysis
4.5.3.1

X-ray powder Diffraction (XRPD)

Polymorphic forms of the compound and the solid state from amorphous 2PNA were
characterized by XRPD. A Rigaku Smartlab diffractometer (The Woodlands, TX) in the BraggBrentano setup with Cu Kα radiation (40kV, 40mA) was used for data collection. Diffraction
patterns were collected at a step size of 0.02° with a scan rate of 4°/min between 4.0° and 40.0°
2𝜃 at room temperature.
4.5.3.2

Differential scanning Calorimetry (DSC)

A Q2000 DSC (TA Instruments, New Castle, DE) fitted with a refrigerated cooling system
(RCS 90) and an auto-sampling unit was used for thermal analysis. Samples were placed in a
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hermetically sealed Tzero® pan/lid system. A constant purge of nitrogen gas at 25 mL/min was
used. The samples were heated at 10 °C/min to above the melting point. An indium standard was
used for temperature and heat flow calibration.
To approximate the nucleation and growth maxima of 2PNA above Tg, a 5 mg sample was
melted in a hermetically sealed pan by raising the temperature to 10 °C above the melting offset.
Then, the sample was cooled at 20 °C/min to various degrees of supercooling. Subsequently,
held isothermally for 1 min, the sample was re-heated at 10 °C/min to 165 °C. The re-heating
curves were examined for exothermic recrystallization and endothermic melting events.
4.5.3.3

13

C solid-state NMR spectroscopy

A Chemagnetics CMX 400 MHz (1H = 400.02MHz;

13

C = 100.59 MHz) spectrometer was

used to analyze solid samples. A samples was packed in a 5 mm zirconia rotor and

13

C spectra

were obtained with cross-polarization/magic angle spinning (CP/MAS), TPPM high power
proton decoupling and total sideband suppression (TOSS) at ambient temperature. Operating
conditions included a spinning speed of 6 kHz, acquisition time of 16 ms, and a 1H pulse width
of 5 s (90°). A delay time of 125 sec (crystalline) or 10 sec (amorphous), and a CP contact time
of 5 ms (crystalline) or 2 ms (amorphous) were used. The

13

C SSNMR spectra were externally

referenced to the carbonyl carbon resonance of glycine at 176.5 ppm. The free induction decays
were processed using Spinsight software (Version 4.3.2) and an exponential line-broadening
factor of 20 Hz was used to improve the signal-to-noise ratio.
Melt spectrum was acquired using a Bruker 300 MHz Ultrashield solid-state spectrometer
equipped with a heating/cooling accessory. The samples were packed in a 7.5 mm zirconia rotor
with a Kel-F endcap. A spinning speed of 4000 Hz was used and a 13C single-pulse experiment
was conducted. The sample was melted by maintaining the temperature at 165 °C. A pulse delay
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of 5 seconds,

13

C 90° pulse of 6.5 s, acquisition time of 69 ms, and 32 scans were employed.

TNMR software (Version 2.11.2, Tecmag) was used for data processing.
1

H relaxation data (T1 and T1) and

15

N spectra were acquired using a Bruker Avance III HD

spectrometer operating at 500.13 MHz for 1H, 50.69 MHz for

15

N, and 125.77 MHz for

13

C,

together with a double resonance probe tuned to 1H and either 15N or 13C, equipped with a 4 mm
MAS stator (Bruker BioSpin, Billerica, MA).

15

N experiments utilized ramped CP with

amplitude ramped on the 1H channel, TOSS, and high power SPINAL64 1H decoupling. The
MAS rate was 8000 Hz for 1H relaxation and 15N experiments. The 1H 90° pulse width was
2.79 s, the 15N 180° pulse width was 9.74 s, and 1H decoupling pulses were 5.11 s, and 15N
experiments utilized a CP contact time of 5 ms. Recycle delays were 12 s for amorphous 2PNA,
60 s for the  polymorph, and 126 s for the  polymorph. The acquisition time was 7.53 ms for
the amorphous sample and 40.14 ms for the crystalline forms. A total of 49572 scans were
averaged for the amorphous 2PNA

15

N spectrum, 3888 scans for the  polymorph, and 3159

scans for the  polymorph. Line broadening of 10 Hz of was employed for the amorphous 2PNA
15

N spectrum and 10 Hz for the spectra of the crystalline materials.
1

H T1 (spin−lattice relaxation) measurements were conducted using a direct-detected saturation

recovery pulse sequence with 16 different  delays. 1H T1 (spin−lattice relaxation in the rotating
frame) measurements were made using a

13

C-detected CP pulse sequence modified to include

TOSS. The 1H spin-lock time was varied from 0.005 to 50 ms with RF field strength of 60 kHz.
Relaxation data and the 

15

N spectra were acquired at 303 K, while the amorphous

spectrum was recorded at 265 K to prevent crystallization during the acquisition.

15

15

N

N chemical

shifts were externally referenced to nitromethane by setting the –NH3 peak of glycine to −347.58
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ppm. Data were analyzed used Bruker TopSpin 3.2 (Bruker BioSpin, Billerica, MA) and Mnova
11.0 software (Mestrenova Research S.L. (Santiago de Compostela, Spain).
4.5.3.4

Hot stage microscopy (HSM)

A Zeiss AX10 microscope (Guttenberg, Germany) with a Linkam hot stage accessory (Linkam
Scientific Instruments, Tadworth, UK) was used to image recrystallized solid samples of 2PNA.
Powdered 2PNA ( polymorph), sandwiched between two cover slips, was heated to 170 °C to
completely melt the sample. The melt was allowed to cool to room temperature and then
reheated at 10 °C/min to observe crystals formed under polarized light. The recrystallized sample
was further analyzed using Raman microscopy using the method specified below.
4.5.3.5

Raman microscopy

A Bruker Senterra Raman microscope equipped with a 785 nm laser and 20X objective was
employed to measure solid samples. A total of 20 co-additions with an integration time of 5
second were used for each measurement with a spectral resolution of 3 cm-1.
4.5.3.6

Variable-temperature Raman spectroscopy

Kaiser RXN2 hybrid Raman spectrometer (Kaiser Optical Systems, Inc., Ann Arbor, MI) with
non-contact PhAT probe (6 mm optics) was used to collect spectra of the melt state of 2PNA. 15
mg of the powder sample was placed in a vial. The sample was heated until it melted and the
Raman spectra were collected as a function of time. A total of 5 co-additions with an integration
time of 1 sec were used for each measurement.
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4.5.4 Computational Analysis
4.5.4.1

Hydrogen-bonding energy calculation

Hydrogen-bonded pairs were extracted from respective optimized crystal structures and
subjected to single-point energy calculations at the B3LYP/def2-TZVP level with dispersion
correction by Gaussian09 (Wallingford, CT). The hydrogen-bonding energy was calculated by
subtracting twice the monomer energy from the energy of the dimer (acid-acid or acid-pyridine)
with the basis set superposition error (BSSE) corrected by the counterpoise method.131
4.5.4.2

NMR chemical shift calculations

NMR chemical shielding was calculated using the gauge-invariant atomic orbital (GIAO)
method.145 2PNA single molecules and dimers were extracted from the respective crystal
structures. Monomers were fully optimized using with B3LYP/6-311++G(d, p) and hydrogen
position in the dimers were optimized using B3LYP/6-311++G(d, p). The structures were then
subjected to the isotropic chemical shielding calculation. The level of theory used for NMR
calculations was B3PW91/6-311++G (2d, 2p). Because the  polymorph has two different
conformers in the asymmetric unit, the calculation was performed on both conformers
respectively. For calculating carbon chemical shifts, tetrametyl silane was used as the reference
molecule while nitromethane was used as the reference for calculating nitrogen chemical shifts.
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4.6

Results

4.6.1 Solid-state characterization
2PNA has four reported polymorphic forms – obtained using evaporative
crystallization technique.100a  and  forms contain carboxylic acid dimer synthon (acid-acid
synthon), while the  andpolymorphs contain carboxylic acid-pyridine N chains (acid-pyridine
synthon) (Figure 4.2). Cooling crystallizations from a variety of solvents at three levels of
supersaturation (1.2, 1.5, and 1.8) could only yield the form. For the current study, the 
polymorph was obtained during the synthesis of the compound. The other two forms appeared to
be difficult to obtain by solution crystallization. The  form, discussed later in the report, could
be obtained by reheating the amorphous form of the compound above its Tg. As reported earlier,
the form is the most thermodynamically stable form at room temperature.100a The  polymorph
can readily convert to the  by solvent mediated phase transition (such as in a slurry
experiment); it generally needs to be stored at 0% relative humidity to prevent conversion. The
XRPD of the two forms are highly distinctive. DSC results show that the  form has lower
melting onset temperature (Tm = 136.4 ℃), lower melting enthalpy (Hm = 55.6 J/g) and melting
entropy (Sm = 0.40 J/g⋅℃), compared with the  (Tm = 153.2 ℃, Hm = 98.5 J/g, and Sm = 0.64
J/g⋅ ℃). According to the heat of fusion and entropy of fusion rule,16 the and  polymorphs are
monotropic.
C SSNMR spectra were obtained of the crystalline ( and  polymorphs), melted, solution,

13

and amorphous states of 2PNA (Figure 4.3). The experimental chemical shift values are
summarized in Table 4.1. Peak assignments of the solid-state spectra were based on the solutionphase chemical shifts (Figure 4.3a), as well as quantum chemical calculations. For the 
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polymorph (Figure 4.3e), the C1 and C5 resonances overlap and appear as a single peak at 156.9
ppm. A similar behavior is observed for C3 and C7. These carbons appear as distinct resonances
in the solution spectrum (Figure 4.3a and Table 4.1). Chemical shift calculation of a single
molecule extracted from the crystal structure shows resonances separated by almost 2 and 1 ppm
between C1 and C5, and between C3 and C7, respectively. The peak overlapping likely resulted
from the crystalline environment which these carbons experience, a notion supported by
chemical shifts calculated for the dimer in the  form. Conversely, the 13C NMR spectrum of the
 polymorph (Figure 4.3d) displays peak splitting for most carbon atoms, attributed to the
presence of two conformationally distinct molecules in the asymmetric unit (Z’=2). Such
splitting is regularly observed for other molecules possessing Z’>1.141b The carbonyl carbon, C6,
of the  and  polymorphs were observed at 174.4 and 169.1 ppm, respectively.
4.6.2 Molecular speciation in amorphous 2PNA
In our previous work of examining the hydrogen-bonding interactions in the amorphous phase
of this compound, acid-pyridine intermolecular interactions were observed and thought to
promote vitrification upon melt quenching.144b In the current study, the molecular speciation of
the glassy phase was further investigated in greater details.
Raman spectra of three 2PNA polymorphs obtained in this study were examined (Figure
4.4A). Characteristic band in the 1050-980 cm-1 region is associated with 2, 4, 6 carbon radial
stretch (ring breathing vibration) (Figure 4.4B).146 This peak of the  polymorph - where the
pyridine N forms hydrogen bonding with the carboxyl of the adjacent molecule - is observed at
1004 cm-1. The peak of the  polymorph – where carboxylic acid dimer is formed - is observed
at 998 cm-1. Variable temperature (VT) Raman spectra show the evolution of this peak as the 
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polymorph went through melting (Figure 4.5). When the sample was heated, the peak became
broadened leading to the appearance of two distinct peaks at 998 and 1004 cm-1. The presence of
both these bands seems to suggest the presence of –COOH…pyridine N molecular interactions as
well as -COOH…COOH interactions in the melt/glassy state.
15

N SSNMR experiments were conducted to further verify this observation (Figure 4.6). The

pyridine nitrogen in the  polymorph shows a peak at −105.6 ppm, while the second peak at
−266.9 ppm represents the imine nitrogen. In the  polymorph, the pyridine nitrogen peak shifts
to −139.3/139.8 ppm, with the peak splitting indicative of Z’=2, and the imine nitrogen was
observed at -279.0/-281.4 ppm. Moreover, the amorphous 2PNA shows three broad resonances
of the pyridine nitrogen at -110.9, -135.0 and -217.9 ppm. The peaks at -110.9 and -135.0 ppm
align well with the corresponding  and the  polymorph peaks respectively. However, the large
upfield shift at the -217.9 ppm resonance is indicative of proton transfer between the carboxylic
acid and pyridine nitrogen,147 suggesting that some molecules became zwitterionic in the
amorphous state.
4.6.3 Crystallization from Amorphous state
Crystallization from the glassy state was examined using SSNMR spectroscopy and XRPD. 1H
T1 and 1H T1 NMR relaxation times of crystalline and amorphous forms were measured (Table
4.2). 1H T1 and 1H T1 are sensitive to motional frequencies in the MHz and kHz regions,
respectively. 1H T1 relaxation times represent global molecular motions because of strong proton
spin dipolar interactions causing all the 1H having a common relaxation time. Amorphous solids
generally exhibit shorter relaxation time and greater mobility than their crystalline counterparts.
With no alkyl group to act as a relaxation sink, the 1H T1 values of crystalline polymorphs are
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expected to be very long. This was observed for the α polymorph with the 1H T1 measured to be
94.7 (11.3) seconds. The 1H T1 of the δ form and amorphous 2PNA were 29.3 (3.4) and 6.7 (0.2)
seconds, respectively.
Crystallization from amorphous 2PNA at 0% relative humidity at room temperature was
monitored by SSNMR over a period of 20 days (Figure 4.7). It can be seen that the amorphous
sample, despite no moisture present in the environment, could eventually recrystallize into the 
polymorph confirmed by both SSNMR and XRPD. Moreover, effect of environmental moisture
on crystallization kinetics from the glassy 2PNA was examined by XRPD. When amorphous
samples were exposed to 0% or 55% RH, the  polymorph crystallized. Exposed to 75% RH, the
amorphous sample transformed to both the  and  polymorphs (Figure 4.8). The characteristic
peak of  polymorph, at approximately 4.0 2𝜃, appeared at 6 hours and the characteristic peak of
polymorph, at approximately 9.8 2𝜃, showed up at 10 hours.
Non-isothermal crystallization from supercooled liquid of 2PNA was examined by heating the
glassy solid that was prepared by melt quenching (Figure 4.9A). On heating the glassy sample, a
Tg event was observed at 44.9 ℃ followed by an exothermic re-crystallization peak at 113.9 ℃.
The melting onset temperature of the re-crystallized solid, 143.7 ℃, corresponds to that of the 
polymorph of 2PNA. Isothermal crystallization experiments using hot stage microscopy verified
the crystallization of  polymorph (by XRPD) (Figure 4.9B); the form was further characterized
by Raman spectroscopy (Figure 4.4A). Formation of the  polymorph seemed to be controlled by
the degree of cooling before reheating the supercooled sample. It was observed that the sample in
the DSC pan must be cooled to around 110 °C to observe an exothermic re-crystallization peak
followed by an endothermic melting event (Figure 4.10). Since greater the number of nuclei
formed, higher the recrystallization enthalpy, it is concluded that the maxima for nucleation for
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this compound is around 60 °C . Moreover, the recrystallization exotherms are seen in the
temperature range of 123 °C -110 °C, indicating that in this region the crystal growth velocity is
rapidly increasing.

4.7

Discussion

Understanding crystallization from the amorphous state impacts formulation design of
amorphous solid dispersions. Physical instability leads to alteration in dissolution rate and
bioavailability, which negates the solubility advantage afforded by the amorphous state.9
Moreover, because the amorphous phase of drugs represents frozen single-component molecular
liquids, phase transition studies provide a unique opportunity to understand molecular events
taking place during early stages of phase transition without the complicating effect of solvent as
compared with solution crystallization. The knowledge of these early molecular events will be
particularly useful in formulation design to target donor or acceptor functional groups by
polymeric excipients to disrupt hydrogen bonding and achieve kinetic stabilization.
Molecular self-aggregates developed in the glassy state during the cooling process are believed
to lead to eventual crystal structures. Our 15N SSNMR data indicates that the amorphous phase of
2PNA formed three intermolecular interaction populations: carboxylic acid dimers, acid-pyridine
hydrogen-bonded motifs, and acid-pyridine ionic complexes (zwitterionic interaction). While not
strictly quantitative due to cross polarization, the area of the three peaks was used to estimate the
quantity of each population. The acid-acid dimers, acid-pyridine hydrogen-bonded molecules,
and acid-pyridine ionic complexes accounted for 30.8%, 13.7% and 55.5% of the overall
pyridine nitrogen signal, respectively. These results indicate that nearly 70% of 2PNA molecules
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are engaged in acid-pyridine interactions, which is in good agreement with our earlier report,144b
while the remaining 30% is organized as acid-acid dimers.
The formation of zwitterionic interaction – involving proton transfer between -COOH and
pyridine group - is supported by estimating the difference in 𝑝𝐾𝑎 between the two functional
groups. The calculated difference value is around 3.9 (pKa of the functional groups were
calculated using MoKa version 2.6.5),148 large enough to suggest proton transfer. Furthermore,
the 15N chemical shifts of pyridine nitrogen of the acid-pyridine zwitterionic hydrogen bonding
was calculated as -217.5 ppm, extremely close to that observed in the amorphous spectra. On the
other hand, the

15

N chemical shifts of pyridine nitrogen of acid-acid dimer and acid-pyridine

motif were calculated as -94.4 and -132.2 ppm, respectively.
With this picture of glassy state in mind, the crystallization outcome under different conditions
may be rationalized. When crystallization was conducted at 0% RH at room temperature, the 
polymorph, containing the acid-acid synthon, crystallized selectively instead of the polymorph,
which contains the acid-pyridine synthon. The  form is the most stable polymorph at room
temperature and is expected to crystallize either directly or through conversion of a metastable
form. The lower probability of crystallization of the polymorph may be due to the presence of
conformationally diverse molecules bound by acid-pyridine interactions.
The effect of molecular mobility on crystallization of 2PNA was examined by exposing the
amorphous samples to high relative humidity. Environmental water is known to act as a
plasticizer and promote molecular motion.149 It was observed that at 75% RH,  and  forms
both crystallized. This observation highlights the effect of water on promoting the formation of
the acid-pyridine chains. This is an important observation with regards to the crystallization
behavior of amorphous samples. While thermodynamics dictates the most stable phase at a given
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temperature and pressure, kinetic conditions such as moisture content may lead to a particular
crystalline form. Crystallization outcome from the amorphous sample is also influenced by the
temperature. When heated above its Tg, the glassy sample crystallized into the  polymorph.
While both  and  forms have the same carboxylic acid dimer as the building block, they differ
in the conformation of the molecules (the major torsion angle, 1 shown in Scheme 1, is 1.8 of
the  form and -163.4/156.8 of the ). At a high temperature, 2PNA molecules can access higher
energy conformers, which permit crystallization of the  in favor of the  polymorph. As shown
in Figure 4.11, the  form bears the lowest conformational energy with regard to 1 and a slight
increase in the energy by a few kJ/mol enables the molecule to adopt quite a large degree of
conformational flexibility.
The current study highlights the internal structure of the amorphous phase. While often
described as a disordered phase, the structure of amorphous phase is not random at the
supramolecular level. While an amorphous solid lacks long-range symmetries found in a
crystalline solid, the glassy phase of small molecules contains certain structural elements that
exhibit short-range order over domains that are too small to demonstrate crystalline
characteristics.50 Irrespective of the temperature, at low relative humidity conditions, the acidacid synthon is preferred in the crystalline state. While both the acid-acid and acid-pyridine
hydrogen-bonded molecules are energetically similar (with the acid-acid synthon more stable by
a few kJ/mol),150 crystallization of the acid-acid pre-nucleation aggregates faces a smaller energy
barrier than the acid-pyridine aggregates. This is mainly driven by the collective intermolecular
interactions gained during the nucleation process. Weaker interactions including van der Waals
and aromatic stacking forces complement the construct of a nucleus from carboxylic acid dimers.
The interaction energy between two layers of acid-acid dimers and acid-pyridine dimer were
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calculated (Figure 4.12). The packing of acid-acid dimers is about 5 kJ/mole more stabilizing
than acid-pyridine dimers. This further supports the claim that packing of acid-acid dimers is
associated with a lower energy barrier. Clearly, while the acid-pyridine interactions are preferred
in the amorphous state, including the zwitterionic forms because of the proton transfer between
the –COOH and pyridine N, the more stable nuclei with the acid-acid motifs are expected to
form, resulting in mostly the  form and rarely the  Only under high RH conditions, nucleation
of the  form seems to be facilitated by the presence of water, possibly caused by enhanced
mobility of the acid-pyridine chains and/or discouraged packing of the acid-acid pairs.

4.8

Conclusions

This study examined the role of molecular speciation in the amorphous state and the
corresponding crystallization outcome. Both acid-acid and acid-pyridine interactions were
observed in the amorphous state, including zwitterionic interaction between carboxylic acid and
pyridine nitrogen using

15

N SSNMR spectroscopy. The crystallization outcome from the

heterogeneous glassy state was dependent on the conditions employed, whether it was the crystal
forms that contain the acid-acid dimer or acid-pyridine motifs. This work provides greater
understanding of the internal structure of glassy state and highlights the role of supramolecular
aggregates in the amorphous state and its relationship to crystallization outcome.
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Figure 4.1. (A) Chemical structures of 2PNA. Primary torsion angle (1) is marked. The carbon
numbering has been specified. (B) The acid-acid synthon (a), the acid-pyridine synthon (b) and the
zwitterionic acid-pyridine synthon (c) found in the crystal structures of 2PNA are shown.
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a

b

c

Figure 4.2. The acid-acid synthon (a), the acid-pyridine synthon (b) and the zwitterionic acidpyridine synthon (c) found in the crystal structures of 2PNA are shown.
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Figure 4.3.

13

C NMR spectra of solution-phase (a), melt (b), amorphous solid-state (c),

crystalline  polymorph (d), and crystalline  polymorph (e) of 2PNA are presented along with
assignment of the resonances.
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Figure 4.4. (A) Raman spectra of 2PNA  polymorph (i),  polymorph (ii) and  polymorph (iii).
(B) An expanded view of the peak corresponding to pyridine ring vibration is shown for 
polymorph (i),  polymorph (ii) and  polymorph (iii). (C) Image of the  polymorph
crystallized from heating the amorphous state and used for Raman measurement.
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Figure 4.5. Variable-temperature Raman spectra obtained by heating  polymorph (from b to e)
and showing the evolution of the pyridine ring vibration band.
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Figure 4.6. 15N SSNMR spectra of (a) amorphous (b)  polymorph (c)  polymorph, of 2PNA.

129

Figure 4.7.

13

C SSNMR spectra showing the crystallization kinetics of amorphous 2PNA at 0%

RH between Day 1 – Day 4 (a-d) and Day 20 (e). Each spectrum reflects the average signal of 24
hours of data collection.
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Figure 4.8. Crystallization kinetics of amorphous 2PNA at 75% relative humidity and room
temperature as observed using XRPD. The arrow in (d) indicates the  polymorph while the
arrow marked in (e) indicates the crystallization of the  polymorph. The reference spectra of the
two forms are shown in (h) and (i).
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Figure 4.9. (A) Comparison of the DSC thermograms of the  polymorph (green) obtained by
heating amorphous 2PNA with the  polymorph (red). (B) XRPD of the experimental 
polymorph (red) with simulated pattern (blue) obtained from single crystal X-ray data.
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Figure 4.10. DSC thermograms of 2PNA showing the heat-cool-heat sequence with the samples
cooled to various degree of supercooling ((a) 60 °C (b) 100 °C (c) 115 °C (d) 120 °C) to identify
the nucleation and growth maxima for the  polymorph.
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Figure 4.11. Conformational energy scans of 2-PNA of a function of its main torsion angle, 1.
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Figure 4.12. (A) Packing interactions between two acid-acid dimers of 2PNA (B) Interactions
between two layers of acid-pyridine hydrogen-bonded 2PNA molecules.
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Table 4.1. Chemical Shift (δ) Assignment for 2-PNA
δa (ppm),
amorpho
us solid
state

Δ3 = δa ˗
δm (ppm)

1.6

156.4

0.8

110.2

-2.1

107.9*

-4.4*

142.5141.8
(142.1)
113.8112.0
(112.9)
151.0

-0.9

140.7

-2.3

-0.9

113.0

-0.8

2.0

152.4

3.4

-0.5

169.9

0.3

0.9

169.9168.4
(169.1)
138.8

-0.4

140.7

1.5

118.3

-4.6

125.0

2.1

119.0*

-3.9*

129.6

130.4

0.8

130.1**

0.5

129.0

-0.6

122.2

124.8

124.4

-0.4

126.9

2.1

121.8 *

-3.0*

C11

128.8

129.6

131.4

1.8

131.8**

1.2

129.0

-0.6

C12

120.0

122.9

120.3

-2.6

125.0

2.1

120.7*

-2.2*

Carbon
number

δL
(ppm),
dmsod6

δm
(ppm),
melt

δs (ppm),
crystallin
e alpha
polymor
ph

C1

155.6

155.6

156.9

1.3

C2

107.6

112.3

105.2

-7.1

C3

140.6

143.0

140.1

-2.9

C4

113.9

113.8

112.9

-0.9

C5

152.7

149.0

156.9

7.9

C6

169.1

169.6

174.4

4.8

C7

139.7

139.2

140.1

C8

120.0

122.9

C9

128.8

C10

Δ1 = δs ˗
δm (ppm)

δd
(ppm),
crystallin
e delta
polymor
ph
(mean)
158.4156.0
(157.2)

*= approximate because of peak broadening
-**= difficult to assign because of peak splitting and overlap

Δ2 = δd
(mean) ˗
δm (ppm)
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Table 4.2. 1H T1 and 1H T1 Relaxation Times of Different Forms of 2PNA.
Relaxation time
1

H T (sec)





Amorphous

94.7 (11.3)

29.3 (3.4)

6.7 (0.2)

383.2 (190.8)

42.0 (5.8)

8.1 (0.1)

1

1

H T  (ms)
1
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CHAPTER 5.

SUMMARY

Amorphous formulations of drug molecules are of growing importance to the pharmaceutical
industry.11e The low aqueous solubility and consequent poor bioavailability associated with the
crystalline state of many newly developed drug candidates has propelled amorphous
formulations into greater relevance.119 However, this high-energy solid-state possesses excess
thermodynamic quantities including free energy, enthalpy and volume, which gradually drift
towards equilibrium values leading to nucleation and subsequent crystallization.11b
Understanding and predicting glass forming ability and crystallization from amorphous solids
remains one of the key questions for successful application of this solid-state in formulation
design.
The primary goal of this research was to develop an understanding of crystallization from
amorphous pharmaceuticals, focusing on examining the connection between thermodynamic,
kinetic and molecular factors impacting crystallization. The novel aspect of this project involved
utilizing a series of structurally similar compounds which allows detailed assessment of the
contribution of functional groups and their interactions on vitrification. It was hypothesized that
there exists a link between thermodynamic quantities, kinetic properties, molecular interactions
and crystallization behavior. Furthermore, it was hypothesized that the structural heterogeneity in
supercooled liquids and glassy state, manifested through intermolecular interactions impacts the
observed crystallization behavior.
Chapter 2 examined the thermodynamic and kinetic aspects of crystallization of structurally
similar organic compounds from the supercooled liquid state by calorimetric and rheological
measurements. Based on their crystallization behaviors, these compounds were divided into three
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categories: stable glass formers (Class III), poor glass formers (Class I), and good glass formers
with poor stability on reheating (Class II). Correlation was sought between thermodynamic
quantities – enthalpy of fusion (∆Hfus), melting point (Tm), driving force for crystallization (∆Gv),
entropy of fusion (∆𝑆fus) – and glass formation based on nucleation and crystal growth theories.
Interestingly, lower entropy of fusion (∆𝑆 fus) was found to correlate with glass formation, in
contrast to the prediction of classical nucleation theory (CNT). Examination of kinetic aspects of
glass formation revealed two important facets of good glass formers: rapid increase in viscosity
on supercooling and high melting-point viscosity as compared with non-glass formers. A linkage
between thermodynamic (∆𝑆fus) and kinetic factors was explored, highlighting the capability of
thermodynamics to impact the observed crystallization kinetics. Furthermore, a broader
relationship was sought between ∆𝑆fus and glass formation by examining several glass formers
from literature. Based on this analysis it is proposed that good glass formers tend to have a ∆𝑆fus
close to 30 X 10-2 J/(cm3 K-1). This work provides a quantitative assessment of glass forming
ability of novel compounds which can be used to select high value candidates from a series of
structural analogs during developability assessment.151
Chapter 3 focused on gaining a molecular level understanding of the propensity of a molecule
to form and remain as a glassy solid by studying the formation of supramolecular assemblies in
the melt state and their impact on crystallization or amorphization. Using variable temperature
FT-IR, Raman and solid-state NMR spectroscopies, the presence of hydrogen bonding in the
melt and glassy state was examined and correlated with observed phase transition behaviors.
Spectroscopic results revealed that the formation of hydrogen-bonded aggregates involving
carboxylic acid and pyridine nitrogen (acid-pyridine aggregates) between neighboring molecules
in the melt state impedes crystallization, while the presence of carboxylic acid dimers (acid-acid
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dimers) in the melt favors crystallization. This study suggests that glass formation of small
molecules is influenced by the type of intermolecular interactions present in the melt state and
the kinetics associated with the molecules to assemble into a crystalline lattice. For the
compounds that form acid-pyridine aggregates, the formation of energy degenerate chains,
produced due to conformational flexibility of the molecules, presents a kinetic barrier to
crystallization. The poor crystallization tendency of these aggregates stems from the highly
directional hydrogen-bonding interactions needed to form the acid-pyridine chains. Conversely,
for the compounds that form acid-acid dimers, the non-directional van der Waals forces needed
to construct a nucleus promote rapid assembly and crystallization 152.
Chapter 4 explored the crystallization from the glassy state of a model Class II compound
(good glass formers with poor stability on reheating). Crystallization from amorphous 2phenylamino nicotinic acid (2PNA) was studied using solid-state analytical methods. We had
previously reported that the amorphous phase of this compound is composed predominantly of –
COOH∙∙∙pyridine N (acid-pyridine) interactions. In this study, our focus was on linking
molecular speciation in the amorphous state to the crystallization outcome. Using spectroscopic
techniques (15N SSNMR and VT Raman) the structure of the glassy state was explored. The
results demonstrated that the structurally heterogeneous amorphous state contains acid-pyridine
aggregates – either as hydrogen bonded molecules or in a zwitterionic interaction – as well as a
population of carboxylic acid dimers. It was observed that the crystallization outcome from the
heterogeneous amorphous phase was dependent of the conditions employed. Under conditions of
room temperature and 0% relative humidity, carboxylic acid dimer containing crystal structure
was obtained. While under conditions of high humidity (>75%) acid-pyridine interaction
containing crystal structure was obtained. This work provides greater understanding of the
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internal structure of glassy state and highlights the role of supramolecular aggregates in the
amorphous state and its relationship to crystallization outcome.
This dissertation work was aimed at developing greater understanding of why seemingly
structurally similar compounds display strikingly different phase behavior as amorphous
materials. A mechanistic understanding of the molecular aggregation events leading to
crystallization from amorphous solids can provide an effective way of inhibiting crystallization
by rational selection of crystallization-inhibiting polymers. Furthermore, this study correlates the
observed thermodynamic (entropy of fusion), kinetic (viscosity) and molecular properties
(hydrogen bonding interactions) for small molecule glass formers. This study provides a
pharmaceutical scientist with the ability to judge the glass forming ability of a set of structurally
similar compounds at the interface of drug discovery and development and select appropriate
excipients for their stabilization.
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